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Tuberculosis and Related Pulmonary Disease
General Aspects
Tuberculosis is an infectious disease that spares neither age, sex, 
race nor nationality. Although capable of infecting almost any organ 
of the body, tuberculosis is most generally associated with the lungs. 
Because of this pulmonary localization, the disease generally spreads 
from man to man via the respiratory route — coughing, sneezing, and 
expectoration all serve as vehicles of transportation for the organism 
carrying it from man to man. Once the tubercle bacilli have gained 
access to the lung tissue, the process of disease is generally slow; 
the development is so slow that often the disease goes undetected 
until the individual has developed an advanced case of tuberculosis. 
Treatment, then, may consist of surgery, prolonged hospitalization 
and/or treatment with a battery of antibiotics. It may be necessary 
for treatment to continue for months and sometimes years before a 
return to good health is achieved. Present evidence seems to indicate 
that once a person is infected there is almost never complete elimina­
tion of the tubercle bacillus from the body.
Following infection with tubercle bacilli, man becomes hypersensi­
tive to the protein of the tubercle bacillus, i.e., if tubercle bacillus 
protein were injected into his skin he would react with a delayed 
(1-4 days) allergic response as evidenced by inflammation — the 
reaction would be localized at the site of injection and would be 
characterized by a red, inflamed area and firmness at the center. This 
is what is referred to as the tuberculin skin test. The skin test serves 
several useful purposes. Since a positive tuberculin reaction indi­
cates presence of tubercle bacilli, the test can be used to screen 
large groups of people; the positive reactors are further followed up 
with X-rays. A positive reaction does not tell how old or how bad the 
infection is, nor does it tell whether the disease is active or healed — 
it merely indicates that the tuberculosis organisms are present in the 
body. Because of this fact a positive test in an adult may not mean 
much unless accompanied by clinical symptoms of disease; however, 
a positive test in young children may be useful in diagnosis of tuber­
culosis as it may indicate active, unhealed tuberculosis, or a recently 
acquired infection.
What about immunity to tuberculosis? Can we immunize or protect 
against the infection just as we do with smallpox, tetanus, and 
diphtheria? There is a vaccine for tuberculosis called BCG (the 
Bacillus of Calmette and Guerin) which contains a bovis variety of 
tubercle bacillus (the type that primarily infects cows); the organisms 
in the vaccine are still viable but they have been grown in an un­
favorable environment so that they no longer will produce disease.
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BCG has the disadvantage of causing reaction to tuberculin, thus 
removing an important screening and diagnostic tool. The protection 
it confers is not considered to be sufficient to justify wide use in 
the United States, where other control methods have reduced risk of 
exposure to a very low level. It is recommended here only for persons 
unavoidably exposed to tuberculosis where they live or in their work 
(laboratory workers, for instance). In other countries, where tuber* 
culosis mortality is high and the risk of infection considerable, 
BCG is routinely given to young children. It is the fond hope of many 
research investigators that a vaccine will be developed to protect 
all people against possible infection with tubercle bacilli.
Despite the fact that the organism responsible for the infection 
was not found until 1882, tuberculosis is an old disease, having been 
described by Hippocrates about 400 B.C. The tubercle bacillus, dis­
covered by Robert Koch, has a rather impressive biological c lassifi­
cation: C lass — Schizomycetes; Order II — Actinomycetales; Family 
I — Mycobacteriaceae; Genus I — Mycobacterium; Species — tuberculo­
sis. In bacteriology, however, this extensive classification is simpli­
fied by merely referring to the organism by its genus and species 
name, i.e., Mycobacterium tuberculosis. Clinically and bacteriologi- 
cally several species of mycobacteria are important. Thus, we have 
M. tuberculosis as the principal cause of tuberculosis in man; M. bovis 
infects cattle primarily, although it can infect man and indeed in 
some European countries is a major cause of human tuberculous 
infection, while M. avium infects fowl.
Unlike other microorganisms, the mycobacteria stain only with 
difficulty, requiring either several minutes in contact with the dye or 
application of heat to force the dye into the cells. Once stained, 
however, the mycobacteria resist decolorization with strong mineral 
acids; this property of tubercle bacilli has led to their designation as 
acid-fast bacilli — i.e., once stained they resist decolorization with 
strong acids.
The tubercle bacilli are very resistant to many chemicals and 
disinfectants, consequently, they pose quite a problem in hospitals 
and sanatoria where one is faced with the problem of sterilizing or 
disinfecting equipment. Fortunately, the organisms are readily killed 
by heat, so that equipment which can be treated by boiling or sterili­
zation by steam under pressure can readily be disinfected. Certain 
equipment, such as thermometers, cannot be sterilized by heat, hence, 
a disinfectant must be used. There probably is not complete agreement 
as to the disinfectant of choice, but those that have been used include 
70 percent alcohol, such phenol-containing agents as cresol, lysol or 
amphyl, and certain iodine containing compounds, to mention a few.
Since methods for the laboratory diagnosis of tuberculosis will be 
discussed in detail in subsequent sections of this manual, at this 
point it is sufficient to say that the major tools available for bacteri- 
ologic identification of tubercle bacilli are microscopy, cultural 
characteristics and animal pathogenicity.
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What is the importance of tuberculosis from the medical viewpoint? 
The tubercle bacillus probably causes more deaths in the United 
States than does any other single microbial agent, in spite of the fact 
that the death rate has steadily declined since the middle 1800’ s. 
World Health Organization statistics reveal that tuberculosis also is 
the most potent international disease known, alone accounting for 
three-fourths of all deaths from infectious diseases occurring after 
age fifteen. In the United States tuberculosis once claimed the lives 
of 200 people per 100,000 population, but today, thanks to medical 
research, refined surgical procedures, and the advent of such chemo­
therapeutic agents as isonicotinic acid hydrazide (INH), streptomycin 
and para-aminosalicylic acid (PAS), the tuberculosis mortality figures 
have dropped to their present level of 7/100,000. This figure is still 
extremely high when compared to such communicable diseases as 
diphtheria, scarlet fever, smallpox, polio and others where the death 
rate is less than one per 100,000.Thus, it can be seen that tuberculo­
sis is an important public health problem which still requires exten­
sive cooperative research on the part of clinicians, bacteriologists 
and administrators before it can be listed as one of the le ss important 
causes of human mortality.
The successful treatment and partial eradication of one disease 
producing agent frequently brings another to the fore — tuberculosis 
is no exception to this statement. We cannot be absolutely certain, 
however, if effective control of true tubercle bacilli has increased our 
awareness of other types of acid-fast bacilli, but regardless of the 
cause, there is no denying that both clinician and bacteriologist have 
become more aware of a somewhat nebulous group of acid-fast bacilli 
that have been dubbed the anonymous or atypical acid-fast bacilli. 
These organisms produce a disease which is clinically very much 
like tuberculosis, however, culturally they exhibit several unique 
characteristics. It was on the basis of these unique properties that 
the term “ atypical”  was introduced, encompassing all those cultures 
in which one or more of the following features existed:
1. Frequently, but not always, the colonies were pigmented and 
smooth.
2. A large percentage of the strains were r e s i s t a n t  to para- 
aminosalicylic acid and often moderately resistant to streptomy­
cin and isoniazid.
3. These strains generally have a lowered degree of virulence 
for guinea pigs and mice than do human and bovine strains.
Because of the fact that these organisms were not able to produce 
progressive disease in the guinea pig, a great deal of skepticism 
hung over early reports of their pathogenicity for man. However, 
repeated isolation of these organisms from sputum and resected lung 
tissue of the same patient, in the complete absence of other patho­
genic organisms, is strong e v i d e n c e  that in these patients the
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“ atypicals”  are the causative agents of human disease. With the 
almost universal acceptance that some of these organisms may be 
agents of disease, certain problems arise, including the following:
1. Are there different kinds or types of anonymous acid-fast 
bacilli, and if so, how are they differentiated?
2. Are they closely related in any way to known mycobacteria? If 
not, how can they be distinguished from existing named species?
3. From whence in nature do these organisms originate?
Let’ s attempt to answer these questions in order. First, there 
apparently are different kinds or types of anonymous acid-fast bacilli. 
At the present time their classification on the basis of speed of 
growth and pigment production has offered the most feasible means of 
differentiation, however, as we learn more about these organisms, 
a more clear-cut and exacting taxonomic scheme will unquestionably 
be developed. The existing method of classification was devised by 
Dr. Ernest H. Runyon and provides for the following four groups:
Group I — Photochromogens. The strains of this group are suffi­
ciently distinct and homogeneous that they have been named Myco­
bacterium kansasii Hauduroy. Unless a search of the literature dis­
closes a prior name, the foregoing will be accepted as the valid name 
for those organisms heretofore classed as Group I Photochromes. 
These organisms have a rather unique property of photochromogen- 
icity; they are never pigmented if grown in the dark, however, if, 
while the cultures are still young and actively growing, they are 
exposed to light, yellow pigmentation occurs within the next 6-24 
hours. If grown in continuous light, this pigment often deepens to 
orange or even brick red. These organisms grow both at room tempera­
ture and 37° C. but their rate of growth is slow, on the order of that 
seen with typical human tubercle bacilli. These same growth charac­
teristics apply also to the next two groups in this schema.
Group II — Scotochromogens. As the name implies, these micro­
organisms are pigmented both in the light and in the dark. The pig­
ment, a yellow-orange, frequently deepens on exposure to continuous 
light. There seems to be general agreement among mycobacteriolo- 
gists that the scotochromes still represent a rather heterogeneous 
group, requiring more definitive tests before they can be accurately 
typed and justifiably given a name. Distinguishing Group II strains 
from pigmented Group III cultures is one major problem still to be 
solved. Aside from the fact that these organisms grow very slowly, 
their pigment production often leads to their confusion with pigmented 
saprophytes.
Group III — Non-photochromogens or Battey strains. By and large 
these strains seem to be non-chromogenic on primary isolation, 
however, not infrequently tan, pink or yellowish colonies appear and 
still others acquire pigment after subculture or prolonged incubation.
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One c h a r a c t e r i s t i c  sometimes seen in this group is that of 
actinomycete-like mycelial-patterns. Many of the Battey strains bear 
striking resemblance to avian tubercle bacilli in certain respects.
Group IV — Rapid Growers. Most of these strains grow within 2-4 
days like the known rapidly growing saprophytes, and, needless to 
say, many group IV strains are undoubtedly saprophytes. Designation 
by some group number is needed only for anonymous or un-named 
organisms, and should not include strains which have been identified 
as some named species. Already one species of the heterogeneous 
rapid growers has been named: Mycobacterium fortuitum.
In a subsequent section of the manual more data will be presented 
for the differentiation of these groups from one another, and methods 
for differentiating the atypicals from known mycobacteria also will be 
discussed. While it is true that representatives of all four groups of 
anonymous acid-fast bacilli have been isolated from sources indicat­
ing pathogenicity for man, it is generally conceded that M. kansasii 
(Group I, Photochromogen) and Battey strains are the most virulent, 
while scotochromes and rapid growers are less frequently isolated 
under circumstances indicating complicity in human disease. It should 
be noted that there is little evidence that infection with the anony­
mous acid-fast bacilli is spread from man to man. This latter would 
suggest some source in nature, other than man, as harboring these 
agents of disease. Other than some recent skin hypersensitivity sur­
veys which indicate that infection with Group III organisms may be 
rather widespread in the southeastern United States, epidemiologic 
investigations probing the source of atypicals in nature are rare and 
undocumented at this time.
From this brief discussion it can be seen that there are a variety 
of acid-fast bacilli capable of causing tuberculosis-like disease. As 
we learn more about these bacteria, some clinical signs and symptoms 
doubtless will be found to be different. Already there are some: e.g., 
poor results of drug therapy in infections with the atypicals. For many 
reasons — clinical, bacteriologic and epidemiologic — it is important 
that all such organisms isolated from man be carefully and properly 
identified. It behooves clinician and bacteriologist alike to be aware 
of these different types of acid-fast bacilli so that more effective 
methods of identification and control may be realized. Further, it 
is hoped that research in fields of treatment, prevention, immunity 
and proper identification may lead to continual declines and ultimate 
eradication, not only of tuberculosis but of similar pulmonary in­
fections caused by other mycobacteria.
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Safety Measures
In the tubercu losis  laboratory today, with the in creased  handling 
of viable  organisms — for culture, animal s tu d ie s  and chemical t e s t s  — 
the p o s s ib i l i t ie s  of laboratory infection are greatly in creased .  B e ­
cause  of this  fac t ,  it becom es n e c e s sa ry  for laboratorians to examine 
and analyze  a l l  factors  that may jeopard ize  their sa fe ty  and then to 
take m easures  to counteract these  hazards.
The primary purpose then for observing the safety measures listed 
below is to protect ourselves and those around us from infection with 
the tubercle bacillus. Always remember that your own safety, as well 
as the safety of others, depends upon your techniques.
Precautionary measures in the tuberculosis laboratory may be 
divided into several major categories.
A. Medical and Health Program
1. P h y s ic a l  examination, including chest  X-ray, i s  required 
before employment.
2. Tuberculin tests are done on all new personnel, and non- 
reactors are urged to be vaccinated with BCG.
3. It is emphasized that fatigue, emotional stress, and malnu­
trition act as contributory factors to the development of 
tuberculosis after exposure.
4. Chest X-rays are recommended every three to six months, 
depending upon the nature of an employee’ s work.
5. Illnesses are reported immediately.
6. Accidents are reported immediately.
7. Fifteen-minute rest periods are allotted in morning and 
afternoon.
B. Contaminated Areas (Definition)
Rooms where specimens are received, cultures transferred, 
infected animals are housed, and where animals are inoculated 
and autopsied, are considered contaminated, as are the outsides 
of containers of specimens, needles, syringes, metal trays and 
all objects used in the transfer of cultures.
C. Procedures in Contaminated Areas
1. Smoking and eating are prohibited in contaminated rooms.
2. Safety hoods equipped with ultraviolet light and exhaust 
fan are provided for processing of specimens, handling pure 
cultures of organisms, and for the inoculation and autopsy 
of animals. The ultraviolet light is turned on for 10 minutes 
before and after the hood is used. Since ultraviolet light can 
injure the eyes and can cause burns, it must be turned off 
when the hood is in use. As an added precaution the work 
area is swabbed before and after use with 5 percent phenol 
or 2 percent saponated cresol.
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3. Before entering any contaminated area ,  make certain you 
have a ll  the equipment you will need. ONCE IN THE CON­
TAMINATED ROOM, DO NOT L E A V E  UNTIL YOUR TASK 
IS CO M PLETED . Should you need additional equipment, a sk  
someone outside the room to get it for you.
4. ALWAYS don gown, mask, rubber g loves ,  sn eakers  and hat 
before entering a  contaminated area.
5. REMEMBER — Everything within the limits of a contami­
nated room is potentially infectious.
a. Do not touch or handle anything in a contaminated area 
with your bare hands. Should you inadvertently handle 
contaminated materials with your bare hands, wash very 
carefully, using plenty of soap; finally, rinse hands in 
some suitable disinfectant (see Section D which follows).
b. NOTHING is  to be brought from a contaminated area  out 
into a  noncontaminated area u n le ss  it i s  f ir st  au toclaved  
or otherwise decontaminated.
6. Make sure the hood is on during all culture or specimen 
manipulations and animal examinations. ALWAYS bear in 
mind, however, that NO HOOD IS 100 P E R C E N T  E F F E C ­
TIVE. T H E R E  IS NO SU B ST IT U T E  FOR C A R E F U L  A S E P ­
TIC TECHNIQUE.
7. When handling infected materials in the hood, work over a \  
inch deep pan containing cheesecloth liberally soaked in 
2 percent cresol.
8. For personal protection in hoods:
a. Use safety pipettors for all liquid cultures; use of oral 
pipettes is prohibited.
b. Before flaming transfer loops or spatulas, clean them 
carefully in flask containing sand and alcohol.
c. Heat-fix all smears immediately.
9. The outside of specimen bottles may have been contami­
nated at the source or by leakage in transit. Therefore, they 
should be disinfected with 2 percent saponated cresol or 5 
percent phenol before handling. The inner metal mailing 
tube should be autoclaved before re-use.
10. All contaminated materials or dead animals are to be placed 
in completely covered containers which should be swaobed 
with 2 percent cresol before leaving the room.
a. All contaminated fluids are discarded into a splash-proof 
can containing 2 percent saponated cresol or 5 percent 
phenol.
b. All contaminated equipment (glassware, etc.) is placed 
in covered metal cans which are autoclaved.
c. Discarded autopsied animals are wrapped in wax paper
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and incinerated.
d. After use, needles, syringes and autopsy instruments 
are placed in covered containers and autoclaved.
e. Laboratory request slips accompanying specimens are 
placed in a paper bag and autoclaved before they are 
handled by the record clerk.
11. Before leaving your work area:
a. Place the cresol-soaked cheesecloth back into a recep­
tacle containing cresol.
b. Swab around the work area with 2 percent cresol.
c. Turn on ultraviolet lights.
12. Remove gown, mask, rubber gloves, sneakers, and hat and 
place them in a covered GI can which is inside the con­
taminated area. AUTO CLAVE THE CAN B E F O R E  REMOV­
ING ANY CLOTHING THEREFROM .
13. Upon leaving contaminated rooms, hands are washed for 
two minutes with soap and water, and rinsed with an effi­
cient disinfectant (see below). If deemed advisable, take a 
shower before dressing in street clothes.
D. Disinfectants
Although a number of different chemical agents have been
suggested as disinfectants for the tubercle bacillus, an exami­
nation of the literature reveals that most results are equivocal.
An adequate disinfectant should:
1. Kill the tubercle bacillus rapidly.
2. Be able to act in the presence of organic materials, such as 
sputum, tissues, etc.
3. Be relatively nontoxic to tissues (in the event that it is to 
be used for skin disinfection).
4. Maintain its disinfectant properties (i.e., remain stable) 
for prolonged periods of time and under diverse conditions.
A word of caution at this point. Each laboratory or clinic has its 
own unique problems insofar as disinfection is concerned, and it is 
the responsibility of each Unit to evaluate the effectiveness of pro­
posed germicides under conditions simulating actual everyday usage.
Since the primary purpose of the study reported below was to find 
a disinfectant which would work in this laboratory, an attempt was 
made to simulate, as nearly as possible, the work surface over which 
most routine diagnostic work is performed. At the present time, two 
types of work surfaces are used: one is a hood with metal-surfaced 
work area, the other a hood area covered with several thicknesses of 
disinfectant-soaked gauze. Hence, the surfaces on which disinfect­
ants were tested included: l) gauze, and 2) metal tabs of the same 
composition as our hood-work surfaces.
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Twelve-ply gauze sponges and metal scraps were cut to 1/4 x 3/8 
inch size and seeded with one drop each of an 8-day old broth culture 
of human, bovine or avian tubercle bacilli and allowed to dry over­
night. Plate counts showed these inocula to contain 10 6 — 10 7 organ­
isms. The gauze and tabs then were dipped into various disinfectants 
(see accompanying tables) for varying time intervals: 15 seconds, 
30 seconds, 60 seconds, 5 minutes, 15 minutes, 30 minutes. Upon 
removal from the disinfectants, the gauze or metal tabs were dipped 
four times into sterile saline to stop the action of the disinfectant and 
subsequently added to a tube of tween-albumin broth.
Broth tubes were read weekly and all positive tubes were sub­
cultured onto Lowenstein-Jensen medium to be sure that the growth 
was not due to contaminants. Any subsequent growth on Lowenstein 
medium was confirmed as acid-fast by making smears and staining by 
Ziehl-Neelsen technique. (See table I).
Conclusions
From tbe foregoing data the following points seem to be indicated:
1. It appears best to have a disinfectant-soaked gauze over the 
immediate work area, preferably, using one of the phenolic 
compounds as disinfectant.
2. Cresol and phenol appear to be the best disinfectants, 
however, they are noxious to the skin and should not be 
used where direct skin contact occurs.
3. The alcohols (70-95 percent ethanol) are generally inef­
fective, primarily because they would have evaporated long 
before their germicidal action was manifested.
4. Both Wescodyne and Amphyl appear to offer good tuberculo- 
cidal action, however, the effectiveness of Amphyl is cur­
tailed on metallic surfaces while the activity of Wescodyne 
is not altered markedly by the metal.
5. There seems to be a variation in resistance of different 
varieties of tubercle bacilli to certain disinfectants; gener­
ally speaking, the bovine and avian varieties are more re­
sistant than the human.
6. Warexin, which has been highly praised by others, was not 
one of the better disinfectants in our hands. It has the added 
disadvantage that (because of rapid deterioration) it must be 
prepared shortly before use, hence, it would not be effective 




EFFECTIVENESS OF D ISINFECTANTS ON GAUZE WORK SURFACES
Disinfectant














70%  Ethanol 30 sec. 60 sec. 60 sec. 5 min. 60 sec. 5 min.
95%  Ethanol 30  min. - 30 min. - 30 min. -
2 %  Creso l - 15 sec. - 15 sec. - 15 sec.
5 %  Phenol - 15 sec. - 15 sec. - 15 sec.
1-1/2% Warexin* 30 sec. 60 sec. 60 sec. 5 min. 60 sec. 5 min.
W escodyne** 15 sec. 30 sec. - 30 sec. 30 sec. 60 sec.
2 %  A m p h y l* ** - 15 sec. 30 sec. 60 sec. 30 sec. 60 sec.
Sa line  control A ll Control Tubes Po s it ive
*  B r a n d  o f  C l o r p a c t i n ;  G u a r d i a n  C h e m i c a l  C o r p . ,  L o n g  I s l a n d  C i t y  1, N e w  Y o r k .
* *  B r a n d  o f  o r g a n i c  i o d o p h o r ;  W est  D i s i n f e c t i n g  C o . ,  A t l a n t a ,  G e o r g i a .  P r e p a r e d  a s  f o l l o w s :  
W e s c o d y n e  — 10%, 95%  E t h a n o l  — 5 0 % ,  W ater  — 40% .
* * *  P h e n o l i c  c o m p o u n d ;  L e h n  & F i n k  P r o d u c t s  C o r p . ,  B l o o m f i e l d ,  N e w  J e r s e y .
TABLE II
EFFECTIVENESS OF D ISINFECTANTS ON METAL SURFACE
C U L T U R E S
Disinfectant
HUMAN BOVINE AVIAN
Living After Dead Living After Dead Living After Dead
Exposure of After Exposure of After Exposure of After
70%  Ethanol 60 sec. 5 min. 60 sec. 5 min. 60 sec. 5 min.
95%  Ethanol 30 min. - 30 min. - 30 min. -
2 %  C reso l 15 sec. 30 sec. 30 sec. 60 sec. 60 sec. 5 min.
5 %  Phenol 15 sec. 30 sec. 30 sec. 60 sec. 15 sec. 30 sec.
1-1/2 Warexin 15 sec. 30 sec. 30 min. - 15 min. 30 min.
Wescodyne 15 sec. 30 sec. 60 sec. 5 min. 15 sec. 30 sec.
2 %  Amphyl 15 sec. 30 sec. 5 min. 15 min. 15 min. 30 min.
Sa line  control A ll Control Tubes Positive .
Collection and Shipment of Specimens
A. Sputum
1. A clean, sterile container should be used for collection of 
the specimen.
2. If the specimen is to be sent through the mail, it must be 
packaged and shipped according to postal regulations (see 
sheet at end of this section, page 14).
3. A 5-10 ml. sample of sputum (not saliva) is adequate for a 
single examination; there is no advantage in collecting a 
larger single sample.
4. An early morning sample of sputum is preferable.
5. If the early morning sample is not adequate in volume, sputum 
may be collected over a 12-24 hour period. Collection of a 
single sample over a longer period of time or the pooling of 
several days’ production has no advantage and in fact may be 
disadvantageous for several reasons: a) the sputum itself may 
be toxic to tubercle bacilli on prolonged exposure; b) associ­
ated organisms also may be harmful to the tubercle bacillus;
c) the degree of contamination of cultures may be increased;
d) all of a large sample or “ pool”  of sputum cannot easily 
and efficiently be concentrated. If some of the successive 
increments to the “ pool”  are negative, as is likely to be the 
case, these negative increments dilute the positive portions, 
making it actually more difficult to find the organisms.
B. Gastric Washings
1. The sample should be collected early in the morning on a 
fasting stomach.
2. Tubercle bacilli may die rapidly in gastric washings. There­
fore, these samples should be processed as soon as possible 
(at most within 4 hours) after collection.
3. If gastric washing specimens have to be submitted with delay, 
as by mailing, they should be neutralized or preserved when 
collected.
C. Urine
1. An early morning voided or catheterized sample is preferable.
2. The 24-hour pooled sample of urine is more likely to be con­
taminated and to contain a lower concentration of living tu­
bercle bacilli.
3. Urine also is toxic to tubercle bacilli.
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D. Other Materials
Since a tuberculous infection may localize in almost any anatomical 
site in the body, the variety of clinical materials which may be sub­
mitted for examination is considerable. Samples of cerebrospinal fluid, 
pleural fluid, joint fluid, pus, bronchial washings, pharyngeal swabs, 
and even feces are received with varying frequency in the tuberculosis 
diagnostic laboratory. With the refined surgical techniques of today, 
portions of resected lung may be submitted for bacteriologic study. 
The collection of these kinds of specimens is not commonly a problem 
for the bacteriologist, nor does their collection involve active cooper­
ation by the patient; with the exception of feces, these are surgical 
specimens, to be collected or taken by the physician or surgeon, with 
at least surgical asepsis. They should of course be transported to the 
laboratory in bacteriologically sterile containers.
Certain of these specimens, e.g. tissues, will not well tolerate 
a prolonged transportation time (decomposition) and, since chemical 
preservatives and tissue fixatives would make cultural bacteriologic 
examination impossible, these examinations are most productive in 
the hospital or sanatorium laboratory where prompt transportation and 
delivery by messenger or orderly is the common practice.
In the bacteriologic examination of resected lung or other surgically 
removed tissue, it is well to enlist the aid or guidance of the surgeon 
who can personally indicate the portion of tissue or lesion most likely 
to be rewarding of bacteriologic examination.
The examination of fecal specimens for tubercle bacilli is not 
frequently requested and is not often of much value. The presence of 
tubercle bacilli in the feces does not necessarily indicate intestinal 
tuberculosis, but is more likely to mean the presence of pulmonary 
tuberculosis, where sputum has been swallowed.
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Postal Regulations on Shipment of Diseased 
or Contaminated Materials
The latest edition (1954) of the U. S. Official Postal Guide on the 
subject of packaging and mailing states:
PA RT 124: Nonmailable Matter 
124.2 Harmful Matter
124.21 General Provisions of Law. Any articles, compositions, 
or materials which may kill or injure another, or injure the 
mails or other property, are nonmailable. This includes but is 
not limited to:
a. All kinds of poison or matter containing poison
b. All poisonous animals, insects, and reptiles
c. All disease germs and scabs
d. All explosives, inflammable material, infernal machines, 
and mechanical, chemical, or other devices or composi­
tions which may ignite or explode.
124.23 Acceptibility if Properly Packed. When authorized 
by the Postmaster General, various of the articles specified 
in this part as being nonmailable may be sent through the 
mails if they conform to special regulations as to preparation 
and packaging and if they are not outwardly dangerous, or of 
cheir own force dangerous or injurious to life, health, or 
property.
Despite the above reference to disease germs there is no descrip­
tion in the new Postal Guide of the proper method of packaging dis­
eased tissues or cultures of microorganisms. In spite of the fact that 
the 1953 edition of the Postal Guide is now obsolete, it was very 
specific in its description of how diseased tissues and/or specimens 
were to be packaged and mailed. From the standpoint of presenting a 
proper method of packaging of such materials, Article 39 of the July 
1953 edition of the U. S. Official Postal Guide, Chapter IV, Mailability 
and Packaging, is reproduced below.
Diseased Tissues and Other Specimens
A. Specimens of diseased tissues, blood, serum, and cultures of 
pathogenic micro-organisms may be admitted to the mail for trans­
mission to United States, State, municipal, or other laboratories in 
possession of permits issued by the Solicitor, certifying that said 
laboratory has been found to be entitled to receive such specimens 
only when enclosed in mailing cases as prescribed in this article.
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However, bacteriologic or unfixed pathologic specimens of plague 
and cholera shall not be admitted to the mails except when pre­
pared specifically as follows:
1. Pathologic specimens of plague and cholera which have been 
immersed for at least 72 hours in four times their volume of 4 
percent formaldehyde gas in water, or other fluid of equal or 
superior disinfecting power for a period sufficient to fix or 
harden the central portions of the specimen, may be admitted 
to the mails if packed in the same manner as herein prescribed 
for other unfixed pathologic tissues in paragraphs 3, 4, and 5 
of this article.
2. Cultures and infectious material of plague, cholera, anthrax, 
undulant fever, and tularemia may be admitted to the mails if 
enclosed in stout glass tubes sealed by fusion of the glass 
and packed in a large stout glass container with a layer of 
absorbent cotton soaked in 4 percent formaldehyde surrounding 
the inner container. The outer glass container shall be closed 
with a rubber stopper or cork of good quality or by fusion of 
the glass. This double glass container shall then be packed in 
accordance with the provisions of paragraphs 4 and 5 of this 
article.
3. Specimens of sputum, feces, pus, unfixed diseased tissue, or 
other infectious material fluid in nature or shipped with non­
disinfecting fluid shall be placed in stout glass containers 
of suitable size (but not more than three inches in diameter) 
closed with a metal cover having a rubber, cork, or paraffined 
paper leakproof washer or with a cork or rubber stopper of good 
quality, or by fusing the glass. Large fixed specimens of dis­
eased tissue may be prepared for shipment outside mail bags 
when packed in accordance with the provisions of the follow­
ing paragraph.
4. The aforesaid glass container shall then be placed in any of 
the following described containers: (l) a cylindrical sheet- 
metal d>ox with soldered joints, closed by a metal screw cover; 
(2) a paraffin-impregnated heavy cardboard container, with ends 
made of metal or a suitable substitute. A sleeve type of clo­
sure may be employed provided that the overlap is at least 
one-third the length of the cylinder and in any case at least 2 
inches. The closure shall be sealed with tape; or (3) a one- 
piece bored wooden cylinder at least three-sixteenths of an 
inch thick in its thinnest part with a threaded screw top.
The screw-top covers shall be provided with rubber or felt 
washers and shall be threaded with sufficient screw threads 
to require at least one and one-half full turns before they 
will come off.
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The glass tubes in the above containers shall be completely 
and evenly surrounded by absorbent cotton or other suitable 
absorbent in quantity sufficient to absorb the contents of 
the glass container if broken.
5. The sheet-metal box with its contents shall then be enclosed 
in a closely fitting wooden or papier-mache box or tube, at 
least three-sixteenths of an inch thick at its thinnest part, or 
in a sheet-metal box or tube of sufficient strength to resist 
rough handling and support the weight of the mails piled in 
bags. The tube shall be tightly closed with a screw-top cover 
with sufficient screw threads to require at least one and one- 
half full turns before it will come off.
6. a. Cultures in solid media, blood, serum, spinal fluid, fixed 
and completely disinfected diseased tissue, and infectious 
materials on swabs shall be transmitted in a stout glass con­
tainer of suitable size (but not more than 3 inches in diameter), 
closed with a plastic or metal cover having a rubber, cork, or 
paraffined paper washer, or with a stopper of rubber, paraffined 
cork, or cotton, the last sealed with paraffin or covered with a 
tightly fitting rubber cap. The tube shall then be packed in a 
single wooden or papier-mache cylindrical box or tube, at least 
three-sixteenths of an inch thick in its thinnest part, or in a 
sheet-metal box or tube of sufficient strength to resist rough 
handling and support the weight of the mails piled in bags.The 
glass container in this box or tube shall be completely and 
evenly surrounded by absorbent cotton or other suitable ab­
sorbent packing material. Cultures in media that are fluid at 
the ordinary temperature (below 45 C. or 113 F.) may be 
mailed if packed in stout glass vials closed by fusing the 
glass and enclosed as in paragraphs 4 and 5 of this article.
b. Large specimens of fixed diseased tissue shall be placed 
in securely sealed glass containers, or in securely closed 
(hermetically sealed or screw-top or approved patent-top) metal 
containers with the necessary preservative fluid. The container 
shall be surrounded by sawdust or other suitable absorbent 
material to protect against breakage or leakage.
7. Specimens of blood dried on glass microscopic slides for the 
diagnosis of malaria or typhoid fever by the Widal test or of 
other conditions shall be sent in any strong mailing case which 
is not liable to breakage or loss of the specimen in transit.
8. Large pathological specimens of fixed disease tissue and ship­
ments of large numbers of small specimens may be prepared for 
shipment outside mail bags. Small specimens of sputum, blood, 
serum, spinal fluid, pus, feces, fixed or unfixed diseased
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tissue, or other material fluid in nature or shipped with fluid, 
forming part of such a shipment shall be placed in stout glass 
containers as in paragraph 3 of this article and individually 
evenly wrapped in absorbent cotton or other suitable absorbent 
material in sufficient quantity to absorb all the fluid in case 
of breakage. Small and large specimens so prepared shall be 
shipped in a strong, securely closed box endorsed in accord­
ance with article 59 (f), and marked “ Specimen for Bacteri­
ological Examination,”  and be transported outside mail bags.
9. Upon the outside of every package of diseased tissue, blood, 
serum, or cultures of pathogenic micro-organisms admitted to 
the mails shall be written or printed the words, “ Specimen for 
bacteriological examination. This package shall be pouched 
with letter mail,”  except that when dispatch is made to non­
stop trains in catcher pouches or large specimens or shipments 
are prepared as prescribed in paragraph 8 of this article they 
shall be marked “ Specimen for Bacteriological Examination.”
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Laboratory Methods
for Processing Clinical Materials
A. Routine Laboratory Procedures for the Treatment of Sputum 
Specimens
1. Number each specimen as it is received in the laboratory.
2. Mark a sterile Petri dish, a sterile 15 ml. screw-cap centrifuge 
tube (16 mm. x 125 mm. culture tube), and a clean microscope 
slide with the same number.* The screw-cap tube should be of 
resistant glass, should be inspected for chips and weak points, 
and the cap must contain a good liner. Remove the cover of the 
Petri dish and lay it upside down on the work surface. Place 
the slide in a horizontal position across the edge of the inverted 
cover and pour the specimen into the bottom half of the dish. 
Discard the sputum bottle in a metal can to be autoclaved.
3. Pick up a sterile wooden applicator stick by grasping it in the 
middle. Then break it and use the two pieces to divide and cut 
the sputum. Violent agitations and spattering are to be avoided. 
Over a black background, select small bits of necrotic, cheesy, 
rusty or bloody material from various portions of the specimen 
and deposit them in the centrifuge tube until it contains from 2 
to 4 ml. If the specimen is thin, a capillary pipette with rubber 
bulb may be used in place of the applicator sticks. In like 
manner, place selected particles on the slide and spread to 
make a smear of convenient thickness.
4. The smears are stained by the Ziehl-Neelsen technique as 
follows:
a. Allow the smear to dry, and fix to the slide by means of 
gentle heat over a flame or electric slide warmer.
b. Place a strip of filter paper, the size of the smear, on the 
slide.
c. Flood the slide with carbolfuchsin and heat to steaming. 
Allow it to stand for 5 minutes without further heating and 
remove filter paper. Slides should be stained individually. 
Mass staining in a common container may allow cross trans­
fer of acid-fast organisms.
d. Wash twice with water.
e. Decolorize in two or three successive solutions of acid- 
alcohol until no more color appears in the washings. (Ap­
proximately 2 minutes.) A longer period may be required for 
thicker smears.
*O ne must  a lw a y s  u s e  NEW s l i d e s  in  t u b e r c u lo s i s  work.
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f. Wash with water.
g. Counterstain with aqueous methylene blue or other appro­
priate stain for 20-30 seconds.
h. Wash with water.
i. Dry in the air over gentle heat.
j. Examine smear with oil immersion lens, taking care to wipe 
the lens well after each examination of a positive smear. 
Three long lines the length of the smear, or 9 short lines the 
width of the slides, are examined.
1) Some laboratories prefer to examine slides for a given 
length of time, in which case 15-30 minutes is the usual 
period. However, examination by area covered is more 
thorough.
k. Results may be reported as follows:
Number of Bacilli
0
1-2 (in entire smear)
3-9 (in entire smear)
10 or more (in entire smear) 
10 or more in most oil 
immersion fields
Report
No acid-fast bacilli found 
Report number found and 
request repeat specimen
Rare acid-fast bacillus found; 
report number seen 
Many acid-fast bacilli found 
Innumerable acid-fast bacilli 
found
Far more important than number of bacilli in preparation, 
however, is the fact that they are present. If clumps of bacilli 
appear, the number of individual bacilli is estimated. It is 
desirable, if time allows, to make culture inoculations ac­
cording to the microscopy findings. If a slide is positive, the 
sediment is diluted in order to get well isolated colonies 
which may be more easily identified. (See $10 below.)
5. Remove cap from centrifuge tube, flame lip of the tube, and 
add to the specimen a volume of digesting agent equal to the 
amount of sputum. The digesting agent most commonly employed 
is heat sterilized 4 percent NaOH, containing 0.004 percent 
phenol red indicator.
6. Tighten all caps and invert to test for leakage. If a tube leaks, 
transfer contents to another sterile tube.
7. Place tubes in a shaking machine and h o m o g e n i z e  for 10 
minutes.
8. Centrifuge tubes for 15 minutes at 2,500 to 3,000 rpm.
9. One by one, remove caps from tubes, pour off supernatant fluid
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into a splash-proof can containing 2 percent cresol, flame lips 
of the tubes and replace caps.
10. Neutralization should be done immediately so specimens will 
not be in contact with NaOH for more than 40 minutes at most. 
Treat tubes individually. With a sterile capillary pipette, add 
sterile 2N HC1* slowly, drop by drop, to each sediment until a 
definite yellow color is obtained. Back titrate with a sterile 
4 percent NaOH* solution in the same manner until the first 
persistent pink tinge appears. Mix each sediment well and make 
a concentrate smear if desired.
For the culture procedure it is recommended that at least 2 
tubes each of 2 different media be used; these 4 tubes are 
arranged in pairs so that each pair consists of one tube of each 
medium. If the microscopy report is negative, pour off the water 
of condensation from all 4 tubes and inoculate each tube with 
approximately 0.1 ml. of the undiluted, neutralized sediment.
If the microscopy report is rare or many, pour off the water of 
condensation from the first pair of tubes and inoculate this 
pair of tubes without dilution. Add one drop of sediment to the 
water of condensation in the third medium tube; then discard 
the remainder of the sediment from the pipette. Mix well, draw 
up the diluted sediment in the third medium tube and divide this 
diluted sediment evenly between the third and fourth medium 
tubes, spreading the inoculum over the surface, having first 
discarded the water of condensation from the fourth medium tube.
If the microscopy report is innumerable, pour off the water of 
condensation from the first pair of tubes, and inoculate this 
pair of tubes with the sediment without dilution. Expel all the 
sediment from the pipette, and rinse the inside of the pipette 
with the water of condensation in the third medium tube by 
drawing it up into the pipette several times. Use this rinsing to 
streak the third and fourth medium tubes, after having discarded 
the water of condensation from the fourth medium tube. Refer to 
the diagrams in figure 1 for clarification.
11. The inoculated culture tubes should be incubated overnight in 
a nearly horizontal position to insure uniform distribution of 
inoculum over the surface of the medium. The next day, bind 
the four (4) tubes with a rubber band, stand them upright in a 
wire basket and reincubate. Examine the cultures after 2 weeks 
and every week thereafter until the cultures are 6 weeks old. 
Negative cultures are commonly reported at 6 weeks and 
discarded.
♦ A good  p ra c t ic e  i s  to  p a r t ia l ly  f i l l  som e  c l e a n  s c re w - ca p  t u b e s  with HC1 and 
NaO H  and a u to c la v e  them. After  u s e ,  they  c a n  be  d i s c a r d e d  with l i t t le  l o s s .
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FIGURE I
and the Dilution of Inoculum
Medium A B A
Here the water of condensation has been poured off from all 4 tubes.
Here the water of condensation has been retained in the third tube
to serve as diluent for an otherwise excessively heavy inoculum.
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One problem facing many laboratories today is a direct result 
of the modem drug era. Many laboratories are finding more 
and more cases of positive microscopic smears and negative 
cultures. The questions arise — are these cells living or dead? 
What is their significance? It has been shown that often these 
microorganisms are in fact viable, however, the constant pres­
ence of anti-tuberculous drugs in the patient has so altered the 
metabolism of the isolated organism that it may take months to 
grow on laboratory media, and it may never grow at all. Several 
methods of coaxing these reluctant bacilli to grow include: 1) 
washing a digested, concentrated specimen several times in 
sterile saline prior to inoculation of media (both solid and 
liquid); 2) periodic transfers of suspected drug-resistant or 
“ drug-affected”  cultures from apparently negative slants to 
fresh slants often coaxes them to grow; 3) the use of a variety 
of enrichment media or 4) prolonged incubation of cultures 
(10-20 weeks) may result in more positive specimens. Certain 
of the above recommendations obviously are not feasible for all 
laboratories and the ultimate decision to adopt any of the above 
procedures should be made in each individual laboratory only 
after careful consideration of the overall problem.
12. Before reporting, all cultures should be confirmed microscopi­
cally. Place a drop of distilled water on a clean slide. Pick a 
typical colony from the culture with a spade (appendix 17) and 
suspend it in the drop of water. Make a smear from surface of 
“ negative”  cultures also. Allow the smear to dry, fix by gentle 
heat, stain by Ziehl-Neelsen technique as described above, and 
examine microscopically for acid-fast bacilli.
B. Routine Laboratory Procedures for the Treatment of Gastric 
Specimens
1. Number each specimen as it is received in the laboratory.
2. Mark centrifuge tubes with the appropriate specimen numbers.
3. Pour off the supernatant fluid from each specimen into a splash- 
proof can containing disinfectant, and retain the sediment. 
Transfer the sediment to a centrifuge tube and centrifuge at 
3,000 rpm. for 15 minutes. Discard the supernatant fluid. If 
the volume of the specimen is not more than 50 ml., time will 
be saved by centrifuging the entire specimen.
4. Smears of gastric washings are not generally made. Microscopic 
examination of gastric washings is considered unreliable by 
some authorities for two reasons:
a. The tubercle bacilli are usually scarce and difficult to find.
b. Often non-pathogenic acid-fast bacilli are present which are 
not distinguishable m i c r o s c o p i c a l l y  from the tubercle 
bacillus.
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5. Treat the sediment with an equal volume of 4 percent NaOH.
6. Process gastric washings exactly as was described above for
sputum specimens. Homogenize 10 minutes in the shaking
machine, centrifuge 15 minutes at 3,000 rpm., and neutralize.
7. Inoculate each of four tubes of medium with 0.1 ml. of the
neutralized sediment.
8. Incubate and examine the cultures as described under A -(11).
C. Routine Laboratory Procedures for the Treatment of Body Fluids
1. Urine
a. Number each specimen as it is received in the laboratory.
b. Mark centrifuge tubes with appropriate specimen numbers.
c. Centrifuge the specimen at 3,000 rpm. for 15 minutes and 
discard supernatant fluid.
d. With a capillary pipette, transfer several drops of sediment 
to a clean microscope slide. If any difficulty is encountered 
in fixing the smear, the slide may first be coated with a thin 
film of Mayer’ s egg albumin fixative. The sediment is spread 
on the slide with the pipette. Fix the smear by gentle heat. 
Stain by the Ziehl-Neelsen technique and examine micro­
scopically.
e. Add to the sediment of each specimen an equal amount of 
4 percent NaOH and homogenize ten minutes in the shaking 
machine.
f. Centrifuge for fifteen minutes at 3,000 rpm.
g. Neutralize as described for sputum.
h. Inoculate four tubes of medium with half the neutralized 
sediment.
i. Incubate and examine the cultures as described under A-(ll).
j. Transfer the balance of the sediment to an “ inoculation 
bottle”  containing 1 ml. of sterile physiological saline.
k. Inoculate a guinea pig subcutaneously in the right groin with 
the saline suspension of the sediment.
l. The guinea pig is autopsied after 6 weeks unless death 
occurs earlier.
2. Cerebrospinal Fluid
a. Identify specimens and centrifuge tubes by number as before.
b. Centrifuge specimens at 3,000 rpm. for fifteen minutes. One- 
half the sediment will be used for smear and culture, and 
one-half for guinea pig inoculation as described below.
c. From the sediment prepare a smear, stain by the Ziehl- 
Neelsen stain, and examine microscopically for acid-fast
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bacilli. At the same time note the presence of any other 
organisms revealed by the counter-stain.
d. If the sediment appears to be microscopically free from 
pyogenic or contaminating organisms, inoculate half of the 
sediment, without chemical treatment, on the usual media, 
and inject one-half into a guinea pig.
e. If the sediment contains organisms other than acid-fast 
bacilli,
1) culture for other pathogens, and
2) treat with 4 percent NaOH as for sputum. Inoculate the 
usual media and a guinea pig.
3. Pleural Fluid
If fluid contains a clot, cut it into small pieces using sterile
forceps and scissors. Treat specimens as a sputum.
D. Miscellaneous Clinical Materials
1. Pus and bronchial washings — treat as described for sputum 
specimens.
2. Feces (modified Petroff’ s method) — Add three volumes of dis­
tilled water to the specimen and thoroughly mix. Add NaCl to 
saturation, let stand 30 minutes, then all bacteria should be 
floating on the surface of the top layer. Skim the top layer with 
a wide spoon. Add an equal volume of 4 percent NaOH to the 
skimmings and homogenize in the shaker for 30 minutes. Neu­
tralize with 2N HC1 and centrifuge at 3,000 rpm. for fifteen 
minutes. Inoculate five tubes of media with the top layer of the 
supernatant fluid and add 1 ml. of the supernatant fluid to an 
inoculation bottle. Decant supernatant fluid, use one-half of the 
sediment to inoculate 5 tubes of media. Add the other half of 
the sediment to the supernatant sample in the inoculation 
bottle and use this to inoculate a guinea pig. A larger number 
of media tubes are used because of the increased likelihood of 
contaminants. Presence of acid-fast bacilli in feces must be 
carefully interpreted, since the organisms may result NOT frrfm 
tuberculosis of the gastrointestinal tract, but merely from 
swallowed sputum!
3. Tissue (tonsils, lymph nodes, etc.) — place specimen in a 
sterile mortar and cut it into small pieces with sterile scissors. 
Add sterile distilled water a drop at a time and grind the mate­
rial thoroughly. Transfer to centrifuge tube with a sterile 
capillary pipette and treat with 4 percent NaOH in the usual 
manner, homogenizing ten minutes in the shaker. Centrifuge 
and neutralize the sediment. Prepare smear from the sediment. 
Inoculate culture media and guinea pig. (If sterile sand is used
24
in the grinding process, allow time for sand and large tissue 
particles to settle. Transfer the supernatant supension to a 
centrifuge tube and process as above.)
4. Swab — transfer swab to centrifuge tube and half-fill with 4 per­
cent NaOH solution. Homogenize 10 minutes in the shaker, 
remove swab and centrifuge. Prepare smear from neutralized 
sediment. Inoculate culture media and guinea pig.
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Technique for Subculturing
Subculture should be prepared if, on primary isolation, the colonies 
are too numerous, too few, or so atypical that culture identification 
by colonial characteristics is difficult. For adequate study of 
colonial characteristics, at least five well-isolated colonies are 
desirable.
1. Number centrifuge tubes and microscope slides for all cultures 
which are to be subcultured.
2. With a sterile capillary pipette, place four drops of sterile dis­
tilled water in each centrifuge tube.
3. Pick a colony from the culture with a sterile wire loop or spade 
and suspend it in the water. This is done by slowly grinding the 
organisms against the side of the tube with the loop or spade and 
gradually suspending them in the water.
4. Transfer a drop of the suspension to a slide, within a circle 
which has been marked with a glass marking pencil. Allow smear 
to dry, fix with gentle heat, stain by the Ziehl-Neelsen tech­
nique, and examine microscopically for acid-fast bacilli.
5. Add about three drops of 4 percent NaOH to each centrifuge tube. 
(Invisible contaminants may be present in the colonies.)
6. Recap tubes and agitate gently to mix.
7. Incubate 10 minutes at room temperature and shake occasionally.
8. Neutralize with 2N HC1 and add 2 to 3 ml. of sterile distilled 
water.
9. With a sterile capillary pipette, inoculate four tubes of medium 
in the following manner:
Tube 1: Discard condensed water from medium tube and streak 
slant with one drop of undiluted sediment.
Tube 2: Thoroughly mix one drop of undiluted sediment with the 
condensed water in tube 2 and streak the slant with a 
portion of it.
Tube 3: Thoroughly mix one drop of the diluted sediment from 
tube 2 with the condensed water in tube 3. Use a few 
drops of this material to inoculate the tube.
Tube 4: Expel all of the diluted sediment from the pipette and 
rinse it with the condensed water in tube 4 by drawing it 
up into the pipette several times. Use part of this to 
streak the slant.
10. Incubate all tubes at 37° C. Examine after 3 days and after 1 
week and every week thereafter for a total of 6 weeks.
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Cultural Characteristics of the Acid-Fast Bacilli 
(Modified Lowenstein Medium)
The acid-fast nature of all colonies must be confirmed by the Ziehl- 
Neelsen or other acid-fast technique of staining before they can be 
identified as mycobacteria or related microorganisms.
A. Colonies of human type tubercle bacilli generally appear in 12 to 
25 days and, because of their luxuriant growth, are termed “ eugonic.”  
They are dry, friable, somewhat rough, buff in color and after a few 
weeks generally measure from 3 to 5 mm. in diameter. Typical colo­
nies have a flat irregular margin with a rough, heaped-up, “ cabbage- 
head”  center. They are easily detached from the surface of the 
medium but are difficult to bring into even suspension.
Human type tubercle bacilli on rare occasions exhibit dysgonic 
growth characteristics. To differentiate these dysgonic strains from 
bovine tubercle bacilli, it is necessary to make further tests, in­
cluding animal inoculations and the niacin test both of which will 
be discussed later.
With a moderate amount of training using modified Lowenstein 
medium one can identify, by colony characteristics and acid-fast 
staining, typical human type mycobacteria, provided it is known by 
previous observations that the cultures are not rapid growers or 
photochromogens. If there is any doubt, however, final typing should 
always be made by the use of laboratory animals.
B. Colonies of bovine bacilli do not grow as rapidly as the human 
type. They usually appear in 25 to 40 days. They are tiny, dysgonic, 
translucent, pyramidal and are usually less than 1 mm. in diameter. 
They adhere to the surface of the medium but are readily brought into 
suspension.
C. Colonies of avian bacilli generally appear in 14 to 21 days. They 
are eugonic, smooth, butyrous or viscid, and hemispherical and may 
have a faint yellow or pink pigment. They are somewhat larger (1 to 
2 mm. in diameter) than bovine type colonies, with a mucoid, tena­
cious consistency but are easily suspended.
D. Saprophytes include several species of various colonial charac­
teristics. Many are smooth, chromogenic, and rapid growing. Others 
lack these characteristics, and it is likewise true that some rapid- 
growers and some chromogens are disease producers. The only test 
of saprophytism is demonstration of its inability to grow on living 
tissue (man or animal). A strain which will not parasitize a laboratory 
animal and is not closely associated with lesions in man may tenta­
tively be assumed to be a saprophyte.
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The most commonly occurring saprophytes in clinical laboratories 
appear to be smooth chromogens which grow at about the same rate 
as avian bacilli. Hence, speed of growth is no indication of culture 
virulence, and it becomes necessary to determine other identifying 
characteristics before reporting results. Most saprophytes grow 
equallywell at 37° C. and room temperature. Colonies of saprophytic 
mycobacteria can be smooth and either chromogemc or nonchromo- 
genic. The majority of these suspend readily, others only with diffi­
culty. Smooth, hemispherical, nonchromogenic colonies should be 
inoculated into guinea pigs and chickens since these characteristics 
would lead one to suspect avian tubercle bacilli.
It is never safe casually to categorize a mycobacterium as a 
saprophyte. At most, one may report “ resembles a saprophyte.”  
Consideration should be given to the number of colonies obtained 
from the original specimen and other evidence concerning possible 
association with human lesions. What a clinician needs to know is 
not whether a given organism is a saprophyte but whether it is a 
pathogen in his special patient.
Saprophytes include well-defined species such as M. phlei and 
M. smegmatis and certain strains of anonymous Groups II, IV, and 
perhaps some Group III strains (see below).
E. Colonies of M. kansasii Hauduroy (Group I Photochromogens) 
grow at about the same rate as tubercle bacilli, or perhaps slightly 
more rapidly at 37° C. from small inocula; growth at room temper­
ature (20° to 25° C.) appears in three to four weeks. Colonies usually 
are smooth and disperse more easily than typical human tubercle 
bacilli; on occasion completely rough strains are encountered. When 
grown in the dark, the photochromes have little or no pigment; how­
ever, if grown in continuous light they are bright yellow to orange or 
brick red. If young, actively growing, nonpigmented cultures are ex­
posed to light for one hour, yellow pigmentation will appear after 
further incubation of from 6 to 12 hours. It is imperative that actively 
growing cultures (about 1 week old) be used to observe this phe­
nomenon, for older, mature colonies show little or no response to 
light. There are other species of mycobacteria that may show intensi­
fication of pigment upon exposure to light. However, the property of 
photochromogenicity herein described is a rapid, unique phenomenon 
among the acid-fast bacilli. Microscopically the organisms are long, 
strongly acid-fast and often appear banded or beaded.
F. Colonies of Group II Scotochromogens have a speed of growth 
comparable to M. kansasii at both 37° C. and room temperature. As 
the name implies, their yellow to orange pigment is present in the 
light and in the dark, although it usually becomes more reddish- 
orange if grown in continuous light. These scotochromogens retain 
their orange pigment when grown on the 7H-9 or 7H-10 medium. As 
opposed to some of the more rapidly growing saprophytes, scoto- 
chromes usually fail to grow at 45° C. Colonies are regularly smooth
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and maybe either eugonic or dysgonic. Microscopically these strongly 
acid-fast organisms vary in size and rarely form cords.
G. The growth rate of Group III Nonphotochromogens (Battey strains) 
at 37° C. and room temperature is similar to that of the previously 
described groups of anonymous acid-fast bacilli. One characteristic 
which may help differentiate these strains from the culturally similar 
avian tubercle bacilli is that most Battey strains do not grow well 
at 45° C., whereas this temperature is generally optimum for most 
avian strains.
Colonies of nonphotochromes are smooth, hemispherical and 
generally have little or no pigment, but occasional strains may have 
a tan or light yellow which is markedly different from the pigment 
observed in the preceding two groups. On rare occasions, most 
notably on prolonged culture, Battey strains may acquire an orange 
pigment indistinguishable from that seen in Group II. Scotochromogens 
of Group III, however, are less deeply pigmented and the color is 
more slowly developed than in the case of Group II Scotochromogens, 
especially on such media as 7H-9. Microscopically these highly 
pleomorphic cells are not as strongly acid-fast as the other groups; 
not infrequently these cells are seen to possess branching filaments 
similar to species of Nocardia.
H. The most distinguishing characteristics of the Group IV (“ Rapid 
Growers” ) is the fact that they grow out in 4 or 5 days from digested 
clinical material and following subculture onto fresh medium, growth 
appears in 48 hours at both room temperature and 37° C. On further 
testing some or most of these strains may prove to be M. fortuitum.
Biochemical methods of differentiating these strains will be dis­
cussed in the section on cytochemical tests. Colonies are non- 
pigmented and either rough like tubercle bacilli, or smooth and moist. 
The organisms are strongly acid-fast. The rough colony strains 
generally form serpentine cords.
With a moderate amount of experience in observing these colony 
characteristics on modified Lowenstein medium, one can become 
quite adept at limiting the possible mycobacterial types of any given 
colony. Following this preliminary limitation, further confirmatory 
tests can be set up to provide a final diagnosis as to species or 
group of the isolated acid-fast organism.
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Preparation of Cultures for Typing 
by Animal Inoculation
The type identification of cultures of mycobacteria by animal inocu­
lation is predicated upon the development of characteristic lesions 
and course of disease and is, therefore, to some extent, related to the 
numbers or dosage of organisms inoculated. To insure proper interpre­
tation of animal results, the inoculum should be standardized. A 
variety of methods is available for standardizing suspensions of 
acid-fast bacilli for animal inoculation.
A. One which combines simplicity with a fair degree of accuracy 
is that involving the use of a Hopkins vaccine centrifuge tube.
1. Place 0.1 ml. of a sterile physiological saline in a sterile 
centrifuge tube.
2. With a stiff wire loop or spade (appendix B-Item No. 16) 
transfer several large typical colonies (6 to 8 spadefuls of 
organisms) from the culture to the tube and grind them 
against the side of the tube, slowly suspending the bacilli 
in the saline.
3. Add saline to the tube until there is a volume of about 7.0 
ml.
4. Allow the tube to stand at room temperature for 1 to 2 
minutes; by this time, the larger clumps of bacilli will 
have settled leaving a relatively fine homogeneous super­
natant suspension.
5. With a sterile pipette, equipped with rubber bulb, transfer 
the supernatant suspension to a second sterile tube.
6. Transfer 1 ml. of the suspension to a clean Hopkins vac­
cine tube. The tube need not be sterile since the aliquot is 
to be used for standardization purposes only and will be 
discarded after measurements are made.
7. Centrifuge at 3,000 rpm. for 15 minutes (horizontal type 
centrifuge).
8. Measure the packed organisms in the tip of the tube. Each 
.01 ml. division of the Hopkins tube is assigned a wet 
weight of 10 mg. (as determined by experimentation). Once 
the concentration of organisms is known, the necessary 
dilutions can be prepared, using the remainder of the 
original suspension.
9. Assume that the wet weight of organisms has been calcu­
lated to be 8 mg./ml. saline; prepare serial dilutions as 
shown in figure 2.
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FIGURE 2
Preparation of Serial Culture Dilutions
5 ml. 1 ml. 1 ml. 1 ml. 0.1 ml.










w  W  w  w  w
3 ml. salin« 4 ml. »alin« 9 ml. salin« 9 ml. salin« 9.9 ml. salin«
Thoroughly mix the contents of each tube before withdraw­
ing the desired amount. The mixing and measurements 
involved in the serial dilutions are made with a 1.0 ml. 
graduated pipette, equipped with a tight-fitting rubber 
bulb. A single pipette can be used for each set of dilu­
tions without introducing an appreciable error.
In calculating the degree of dilution of the original sus­
pension necessary to yield the desired concentration in mg. 
per ml. in the first dilution tube, the following principle 
is observed on the basis of the foregoing example: Since 
the concentration of organisms in the original suspension 
is 8 mg./ml., the desired concentration of 5 mg./ml. repre­
sents 5/8 of the original concentration. Therefore, to arrive 
at the desired concentration take five parts of the original 
suspension and dilute to eight parts by adding three parts 
of saline. It is only necessary to choose the volume of the 
“ parts”  in such a way that the final volume of diluted sus­
pension will be adequate for the needs of the test.
10. It is important that subcultures be made each time a sus­
pension is prepared for typing by animal inoculation, in 
order to:
a. Have a fresh culture of the organisms available for re­
peating virulence tests in the event the animal dies 
prematurely.
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b. Check the viability of the culture.
c. Correlate colony characteristics with animal results.
11. Prepare subcultures by inoculating each of four tubes of 
media with 0.1 ml. of the 10"4 dilution. Slant culture tubes 
overnight at 37° C. Bind tubes with a rubber band, stand 
them upright in a wire basket and reincubate. Examine at 
weekly intervals and hold until animal report is available.
B. Turbidimetric Standardization:
Because of its versatility, light has been a very effective tool 
to chemists, and more recently to biologists, in a variety of 
ways. If directed at or through a solution, suspension or other 
substance, light may be absorbed, reflected, scattered, re­
fracted and impeded, to mention a few possible changes. The 
construction of instruments to measure these light changes and 
thence convert them into quantitative analytical data has been 
a boon to science. Two of the more important applications of 
light analysis in the field of bacteriology are nephelometry 
and turbidity. Nephelometry is the science of measuring the 
amount of light scattered or reflected by the particles of a 
suspension. In bacteriology this becomes an important tool for 
measuring growth rates. Nephelometry is a very delicate tech­
nique and finds important application in the study of low 
population bacterial suspensions wherein the turbidity of the 
broth culture is often below that visible to the human eye. 
Generally speaking, the bacteriologist in a tuberculosis lab­
oratory is more apt to be dealing with a very dense bacterial 
suspension of known concentration from which he can make 
appropriate dilutions for animal or culture inoculations. Where 
the bacterial suspension is sufficiently concentrated to inter­
fere substantially with the transmittance of light, the concen­
tration of the suspension can be measured by determining its 
percent transmission. This latter technique is called Turbidity, 
and is defined as the proportion of incident light stopped by 
unit depth of sample. If turbidity measurements were to be 
used to measure bacterial concentration, one would merely 
have to set up a standard curve of percent transmission (or 
optical density) vs. either number of viable organisms (as 
determined by bacterial plate counts) or wet weight of cells 
(determined by Hopkins tube); all subsequent standardization 
of suspensions could be made using the standard curve. An 
example of the preparation and use of a standard curve is 
given below. The data were made using a carefully suspended 
culture of the human strain H37Rv.
The culture is first ground up very carefully in saline or other 
diluent as described under the Hopkins tube technique. The 
turbidity or percent transmission of the suspension can be 
determined on a variety of instruments — colorimeter, nepho-
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colorimeter, spectrophotometer, etc. — all of which operate on 
the principle that the intensity of light passing into a solution 
or suspension emerges decreased in intensity, and further that 
this drop in intensity of the emergent beam is proportional to 
the concentration of substance in solution or suspension. To 
prepare the standard curve, then, it is necessary to first place 
a “ blank”  tube in the path of the light beam. This blank tube 
contains the diluent (saline, broth or water) which was origi­
nally used to suspend the bacilli. Since this “ blank”  contains 
no organisms, the instrument is adjusted to read 100 percent 
transmission or zero optical density. Bacterial suspensions of 
varying, but known, concentrations are then placed in the path 
of the light beam. Since such suspensions contain particulate 
matter, they will impede the passage of light, resulting in a 
decrease in the percentage of light transmitted. These data 
may then be tabulated as in table III.
TABLE 111*
COMPARISON OF THE WET-WEIGHT OF BACTER IAL CE LLS  
WITH O PT ICAL DENSITY (OR PERCENT  TRANSMISSION**)
Weight of Cells Optical Density Percent Transmission







*  D a t a  o b t a in e d  fro m  a  C o le m a n  M o d e l 9 N e p h o - c o lo r im e te r ,  u s in g  a 
# 8 -2 0 9  g r e e n  f i l t e r ,  t r a n s m it t in g  a t  5 2 5  m m u.
* *  P e r c e n t  t r a n s m i s s i o n  m ay  b e  c o n v e r te d  to  o p t i c a l  d e n s i t y  u s in g  th e  fo r m u la : 
l o g . -  (1 0 0 )  — O p t i c a l  D e n s i t y .
% T
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By plotting this data on a graph we obtain the curve shown in 
figure 3. Now then, how is this curve used? Suppose a bacte­
rial suspension is prepared which has an optical density of 0.5; 
by checking the standard curve, it can be seen that such a 
suspension would contain about 10 mg./ml. Suitable dilutions 
could then be made to contain 5 mg./ml. and 10 -1 mg./ml. as 
described under the Hopkins tube procedure. If the standard 
curve is to be plotted on ordinary graph paper, it is best to 
use optical density measurements, since they will yield a 
straight line curve whereas percent transmission vs. weight of 
cells produces a curved graph which is sometimes more diffi­
cult to interpret.
Care must be taken in using turbidity measurements, since the 
data varies depending upon particle size in suspension; for this 
reason a standard curve must be prepared in each individual 
laboratory. Since some acid-fast bacilli can be suspended 
more readily and in finer dispersion than others, it is suggested 
that standard curves be prepared for major types of cultures 
with which one might deal: human, bovine, avian, and sapro­
phyte. Once the standard curves are prepared, the turbidity 
technique offers many attractive advantages:
1. Ease, speed and time saved.
2. None of the sample suspension need be lost (if sterile 
turbidity tubes are used) whereas the Hopkins tube entails 
loss of a 1 ml. aliquot for cell weight determination.
3. Accuracy and reproducibility.
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FIGURE 3
Comparison of wet weight of bacterial cells with optical density or percent transmission
Typing of Cultures by Animal Inoculation
A. If Colony Characteristics Indicate: (See Table IV)
1. Human — inoculate 1 ml. of a 5 mg./ml. and 1 ml. of a 1 0 '1 
mg./ml. suspension subcutaneously in the right groin respec­
tively of two guinea pigs.
2. Bovine or dysgonic human — inoculate 1 ml. of a 5 mg./ml. 
and 1 ml. of a 10 '1 mg./ml. suspension subcutaneously in 
the right groin respectively of two guinea pigs and 1 ml. of a 
10"1 mg./ml. into the marginal ear vein of a rabbit.
3. Avian — all chickens must be tuberculin tested with avian 
tuberculin two days before inoculation. The inoculation is 
made intradermally into one of the wattles. An easily visible 
swelling in 48 hours indicates a positive reaction. A repeat 
tuberculin test may be performed 2 to 3 days before the chicken 
is sacrificed. Inoculate 1 ml. of a 5 mg./ml. suspension of 
organisms into a chicken intraperitoneally, or intravenously 
into the wing. If a chicken is not available, a rabbit may be 
inoculated intravenously with the same dose of suspension.
4. Other acid-fast bacteria — inoculate 1 ml. of a 5 mg./ml. sus­
pension subcutaneously into the right groin of one guinea pig 
and 1 ml. of a 10"1 mg./ml. suspension into another.
Rabbits are sacrificed after 3 months.
Guinea pigs are sacrificed after 6 weeks.
Chickens are sacrificed after 3 months.
B. Autopsy Results and Their Interpretation (See Table V)
1. Rabbits — those inoculated with cultures of bovine tubercle 
bacilli may die within 3 months with a generalized tuberculosis. 
Lesions are observed in the lungs, spleen, and liver. Those 
receiving human tubercle bacilli usually survive and are sacri­
ficed at the end of 3 months. There may be a few small lesions 
in the lungs and kidneys. Avian bacilli inoculated intravenously 
into rabbits give rise to the Yersin type of disease which is 
characterized by the absence of macroscopic tuberculous 
lesions. However, acid-fast bacilli may be found in smears of 
liver, spleen, and other organs. If the rabbit dies in less than 
6 weeks, autopsy and/or reinoculate another animal.
2. Guinea Pigs — animals inoculated either with cultures or patho­
logical material are sacrificed and autopsied at the end of 6 
weeks unless they die prior to that time. Record the extent of 
infection in the following manner, based on the distribution of
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macroscopic lesions noted and confirmed by microscopic dem­
onstration of acid-fast bacilli.
No involvement
Inguinal lymph nodes only
Iliac and inguinal lymph nodes only
Lymph nodes and spleen
Lymph nodes, spleen, and liver
Lymph nodes, spleen, liver, and lungs
Lungs only
. . .negative 
. . .doubtful (l+) 
. . .doubtful (2+) 
. . .positive (3+) 
. . .positive (4+) 
. . .positive (5+) 
. . .spontaneous
(not caused by 
inoculum)
Cultures of human and bovine bacilli both give rise to a pro­
gressive, usually fatal, disease in guinea pigs with lesions in 
inguinal lymph nodes, abdominal nodes, spleen, liver, and 
lungs. Other acid-fast bacteria seldom progress beyond the 
inguinal and iliac lymph nodes.
If a guinea pig which has been inoculated with a routine speci­
men of pathological material (not a culture) shows only a mini­
mal involvement (inguinal and iliac lymph nodes) on autopsy, 
a portion of the tissue should be cultured and reinoculated 
into a second animal in order to confirm the diagnosis.
Involvement of only the inguinal and iliac lymph nodes is con­
sidered doubtful because this may occasionally be produced by 
other acid-fast bacteria. If a guinea pig dies in less than 28 
days and is negative, the test should be considered unsatis­
factory. If on autopsy a guinea pig presents a picture of exten­
sive lung tuberculosis only, one should suspect spontaneous 
infection. Virulence tests should be repeated if autopsy find­
ings are questionable. Proper interpretation of results must 
include a consideration of the dosage used.
3. Chickens - Cultures of avian bacilli inoculated into chickens 
give rise to progressive disease with lesions in the spleen, 
liver, kidneys, and mesenteric lymph nodes. Inoculation with 
mammalian tubercle bacilli usually does not cause lesions in 
chickens. Occasionally, however, an abscess forms at the 
site of inoculation. Smears should be made from organs showing 
evidence of gross pathology. These should be stained by the 
Ziehl-Neelsen technique and examined microscopically for the 
presence of acid-fast bacilli. If the chicken dies in less than 
6 weeks it should be autopsied and if results indicate, another 
chicken should be inoculated.
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TA BLE  IV
ANIMAL INOCULATION CHART
Days
Culture Type Dosage Route Animal Until
Autopsy
Human or 1 0 '1 mg. subcutaneous guinea pig 42
A typ ica l Human 5 mg. subcutaneous guinea pig 42
B ov ine  or 5 mg. subcutaneous guinea pi g 42
1 0 "1 mg. subcutaneous guinea pig 42
D ysgon ic  Human 1 0 '1 mg. intravenous rabbit 90




A c id -fa st
5 mg. subcutaneous guinea pig 42





Guinea Pig Rabbit Chicken
Human + + + + CD -
Bovine + + + + + + + -
Av ian - ±  (Yersin)(2> + + +
(1 )  N o r m a l ly  th e  o n ly  d i s e a s e  s e e n ,  i f  a n y ,  fo l lo w in g  in t r a v e n o u s  in o c u la t io n  o f 
r a b b i t s  w ith  h u m an  v a r i e t y  t u b e r c le  b a c i l l i ,  i s  i s o l a t e d  l e s i o n s  in  th e  lu n g  
a n d  k id n e y .
(2 )  T h e  Y e r s in  r e a c t io n  i s  c h a r a c t e r i z e d  b y  a b s e n c e  o f  m a r c r o s c o p ic  d i s e a s e  
b u t p r e s e n c e  o f  l a r g e  n u m b e rs  o f  a c i d - f a s t  o r g a n i s m s  in  m ic r o s c o p ic  
s e c t i o n s  o f  th e  s p l e e n ,  l i v e r ,  lu n g  a n d / o r  k id n e y .
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C. Pathogenicity of the Anonymous Acid-Fast Bacilli for Laboratory 
Animals.
In the experience of this laboratory there is no laboratory animal 
which consistently and reproducibly demonstrates the virulence 
of these organisms. For the main, clinicians and bacteriologists 
have been satisfied that consistent isolation of the same organism 
from repeated samples of sputa and later perhaps from resected 
lung tissue — in the absence of other disease agents — constitutes 
significant evidence of the pathogenicity of these strains for man, 
Koch’s Postulates notwithstanding. The results of pathogenicity 
studies in laboratory animals are indicated below.
1. M. kansasii (Group I Photochromogen) is undoubtedly the most 
pathogenic of the anonymous strains for laboratory animals. 
The usual subcutaneous and intraperitoneal routes of inocula­
tion generally are innocuous for the guinea pig, even with as 
much as 5 mg. of inoculum. Some investigators report that 
intracardial inoculation of 1 mg. of organisms into guinea pigs 
often results in death within 4 to 5 weeks. Only rarely has the 
latter been observed in this laboratory and indeed, in our 
experience; it is more usual to find little progressive infection 
following intracardial inoculation. On the other hand, mice 
seem to be a little more susceptible to infection than guinea 
pigs. The intravenous inoculation of 0.01 to 0.1 mg. of organ­
isms may result in the formation of macroscopic lesions in 
lungs and spleen and more rarely in the liver and kidneys. As 
in the case of guinea pigs, mice are not sufficiently suscepti­
ble to these microorganisms to warrant their use as the sole 
laboratory animal.
2. Group II Scotochromogens exhibit essentially no pathogenicity 
for the usual laboratory animals.
3. Group III Nonphotochromogens are less consistent than strains 
of M. kansasii in producing infection in laboratory animals. 
Some strains appear to be highly virulent while others behave 
like saprophytes, indicating either that this group is still a 
heterogeneous mixture or that there are several variants within 
the group. As in the case of M. kansasii, Battey strains are 
more pathogenic for mice than for guinea pigs, but in neither 
case is the animal data reliable enough to warrant their use 
for pathogenicity tests.
4. Group IV Rapid Growers appear to be comprised both of true 
pathogenic species and of saprophytic strains recoverable from 
sources unassociated with disease. Of the apparent pathogenic 
strains, the rough colony variants and M. foTtuitum  show viru­
lence for mice following intravenous inoculation. It is not un­
common for the mice to die following inoculation. At autopsy 
the most notable lesions are seen in the kidneys.
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From the foregoing it can be seen that there is no laboratory 
animal whose pathologic picture, following infection, consistently 
and reliably demonstrates the pathogenicity of the atypicals for 
man. One technique, the intracutaneous inoculation of guinea 
pigs, appears to offer better correlation of cultural pathogenicity 
for man than do any of the other animal virulence tests herein 
described. Until some more reliable pathogenicity test is obtained, 
this intracutaneous technique offers considerable promise as an 
economical relatively rapid test of culture virulence. The intracu­
taneous inoculation of guinea pigs has been used in the past to 
determine the virulence of saprophytic and mammalian acid-fast 
bacilli. It has been pointed out previously in this section of the 
manual that the groups of anonymo'us mycobacteria are relatively 
innocuous for guinea pigs when administered via the usual sub­
cutaneous, intraperitoneal, and often intracardial routes. Studies 
in this and other laboratories have shown that the results of intra­
cutaneous challenge of guinea pigs with these strains possibly 
may provide closer correlation of culture virulence for man. 
Results of this test may be read in 7 to 21 days and as many as 
four cultures may be inoculated into one animal, so the obvious 
advantages of speed and economy are readily recognized. In 
performance of this procedure, culture suspensions containing 1.0 
mg./ml. and 0.1 mg./ml. are prepared and 0.1 ml. volumes of each 
are inoculated into the quadrants of the shaved abdominal surface 
of the guinea pig. To avoid possible errors arising if the inoculum 
is inadvertently administered subcutaneously, this laboratory 
prefers to duplicate all inocula. From the standpoint of economy, 
however, it is possible to use only one inoculum per culture (1.0 
mg./ml. is recommended) and if one is careful to raise a bleb at 
the site of each inoculum, it is not necessary to duplicate inocula.
The site of inoculation is observed at 3- or 4-day intervals and 
any changes noted are recorded. A positive test is indicated by 
the formation of a persistent open ulcer at the site of inoculation. 
Using this technique all virulent human, bovine, and avian strains 
produce open ulcers, whereas saprophytes produce no lesion, or, 
at most, an area of induration which soon fades. In the experience 
of this laboratory about 85 percent and 75 percent respectively of 
strains of M. kansasii and Group III Nonphotochromogens yield 
open ulcers. These two groups generally are considered the most 
virulent of the anonymous acid-fast bacilli for man. The scoto- 
chromes and rapid growers, considered to be much less virulent 
than the other two groups, cause fewer open lesions by following 
this procedure. Until such time when a laboratory animal can be 
found which will consistently and reliably indicate the virulence 
of the atypical acid-fast bacilli for man, the intracutaneous route 
of challenge appears to offer much promise.
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Cytochemical Tests
At the outset it should be pointed out that final typing and virulence 
determination of the mycobacteria (human, bovine, avian, and sapro­
phyte) should be reported only after adequate biochemical and/or 
animal pathogenicity tests have been performed and recorded. It is 
recognized that the foregoing thesis falls down in two major areas. 
First, there is no laboratory animal which can provide a reliable 
measure of the pathogenicity of atypical acid-fast bacilli. Secondly, 
it is realized that many laboratories are ill-equipped to perform 
animal pathogenicity tests. It is for this latter reason primarily that 
cytochemical tests are being discussed in this manual. It is hoped 
that those laboratories which are unable to perform animal patho­
genicity tests may be able to achieve some degree of typing and 
virulence determination of acid-fast bacilli by performing a number 
of relatively simple cytochemical tests.
For many years research workers have sought simple and rapid in 
vitro tests for the differentiation and virulence determination of 
acid-fast bacilli. Because of inconsistencies in results many of 
these “ test-tube procedures”  have been disregarded. However, cer­
tain of these tests have had widespread acceptance and others are 
looked upon with much favor. Those cytochemical tests which appear 
most popular and most reliable will be discussed in detail while 
others, adequately described in the literature, are listed in the 
bibliography.
1. The Neutral Red Test as described by Middlebrook and Dubos 
in 1948, is performed as follows: Several colonies are picked 
from a culture slant and added to 5 ml. of 50 percent methyl 
alcohol; after incubating at 37° C. for 1 hour the alcohol is 
decanted and the alcohol washing procedure repeated with 5 
ml. of fresh 50 percent methyl alcohol. The alcohol is again 
decanted and the colonies resuspended in 5 ml. of fresh (not 
over 3 to 4 weeks old) barbital buffer (5 percent NaCl + 1 per­
cent Na barbital) to which is added 1 ml. of aqueous neutral 
red (20 mg. percent); this suspension is then held at room 
temperature for 30 minutes before reading. Neutral red has a 
yellow color in this alkaline barbital buffer; however, if the 
dye becomes fixed by the cells, the latter acquire a red color 
in a yellow supernatant fluid. Dubos and Middlebrook noted 
that it was the virulent bacilli which bound the dye, while 
avirulent strains remained yellow, hence, the neutral red test 
is used to distinguish virulent mycobacteria from avirulent 
strains. As originally described, the neutral red test is rather 
time-consuming, requiring at least 3 hours to perform. Several 
modifications of the test have provided considerable savings in 
time. One, devised by Wayne et al. (see bibliography), entails
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the use of the millipore filter. Another modification, performed 
at CDC, requires the use of Herrold’ s egg yolk agar, notably 
different from other egg media in its lack of added mineral 
salts and asparagine. The procedure for the CDC modified test 
follows. Several colonies of the organism in question are 
picked from Herrold’ s egg yolk agar and suspended in 5 ml. of 
the barbital buffer described above; one ml. of the aqueous 
neutral red is added and after standing 15 minutes at room 
temperature the results are read. It should be pointed out that 
while the neutral red test is helpful to tuberculologists, neither 
it nor any other single cytochemical test should be relied upon 
for final virulence determination. If there is any element of 
doubt about a given culture, animal pathogenicity and other 
confirmatory tests should be performed before final reports 
are issued.
2. The observation of Cord Formation also may provide some 
helpful information regarding virulence of the acid-fast bacilli. 
As originally described by Middlebrook et al., it was noted 
that virulent strains of tubercle bacilli tended to orient them­
selves in close proximity to one another in the shape of ser­
pentine cords. If these “ cords”  are carefully examined under 
the oil immersion lens, they are seen to be made up of individ­
ual bacilli lying side-by-side and end-to-end in parallel align­
ment. This phenomenon is best observed in media containing 
no tween 80 or other wetting agents, e.g., tween-less albumin 
broth. In this laboratory it has been possible to demonstrate 
beautiful cord preparations using the water of condensation 
from an egg slant. In the event there is no such water, 0.5 ml. 
of sterile saline may be added to the slant and a portion of 
one colony ground into this fluid; after several days in the 
incubator, a loopful of this added saline may be removed to a 
microscope slide, heat-fixed and stained by Ziehl-Neelsen or 
other acid-fast procedure. Upon examination under lOOx magni­
fication, the serpentine cords, if present, are clearly visible.
3. The Niacin Test of Konno is used to distinguish human strains, 
regardless of virulence, from most other acid-fast bacilli. The 
test is based on the fact that human strains produce more 
niacin than any of the other commonly encountered acid-fast 
bacilli. Notable exceptions to this statement are U. microti 
(vole bacillus) and M. ulcerans, both of which may be niacin 
positive. This niacin can be detected by the use of several 
chemicals which combine with the niacin to form a yellow color 
complex. It has been the experience of this laboratory that a 
recent modification of the niacin test, devised by Runyon, is 
more economical and more reliable than the original procedure 
of Konno. Runyon’ s test is performed as follows: Sterile water 
or saline (0.5 — 1.0 ml.) is added to the culture slant and the 
tube is placed so that the fluid layers over the colonies. If
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niacin is present, it will be extracted in 5 or 10 minutes. A por­
tion of the fluid (0.25 —0.5 ml.) is removed and equal quanti­
ties of aniline* (4 percent in ethyl alcohol) and cyanogen 
bromide* (10 percent aqueous) are added. (Fume hood should 
be used for cyanogen bromide.) If niacin is present, a yellow 
color forms almost immediately throughout the solution. It is 
recommended that an alkaline germicide (cresol with NaOH) be 
added to check tear gas formation prior to discarding the tubes. 
When evaluating his modified test on cultures grown on a vari­
ety of media, Runyon found that most media gave good results, 
with the exception of blood agar; aqueous extracts of the latter 
were pink, thereby obscuring the yellow color of the niacin 
test. This test is very reliable in that most niacin positive 
strains encountered in the diagnostic laboratory can safely be 
labelled as human varieties. The fact that a culture is niacin 
negative, however, does not preclude the possibility that it is 
of the human variety. It should be reiterated that the niacin test 
is not indicative of virulence, but rather, it distinguishes 
human strains, regardless of virulence, from most other acid- 
fast bacilli.
4. Catalase Test. It is a well known fact that acid-fast bacilli 
produce the enzyme catalase. It has been shown that tubercle 
bacilli which become resistant to isoniazid will lose, or ex­
hibit a lowering of, their catalase activity. This loss of cata­
lase activity also has been correlated with attenuation in viru­
lence of said microorganisms for the guinea pig. The suggested 
correlation between catalase activity and virulence of myco­
bacteria prompted a study by Schweiger et al. which demon­
strated that it was possible to distinguish virulent from aviru- 
lent mycobacteria on the basis of catalase activity. Studies in 
this laboratory have shown that it is possible to subgroup the 
acid-fast bacilli on the basis of their catalase activity at 
different temperatures and pH.
In this laboratory, catalase tests are performed in two ways: 1) 
For determination of catalase activity at room temperature, 0.5 
ml. of a 1:1 mixture of 10 percent tween 80** and 30 percent 
hydrogen peroxide*** is added directly to the culture slant held 
at room temperature. 2) To determine the effect of temperature 
and pH on catalase activity, several spadefuls of growth are 
scraped from a culture slant and added to 0.5 ml. of the appro­
priate buffer solution, and thence held in a water bath of proper
♦ T h e se  s to c k  so lu t io n s  m ay b e  p rep a re d  and  s to re d  in  brown b o t t le s  in  the 
re fr ige ra to r . T h e s e  so lu t io n s  w ill k e e p  3 to 4 w e e k s  or lo n g er . If e ith e r  
s to c k  so lu tio n  c h a n g e s  co lo r  or p r e c ip i t a t e s ,  it  sh o u ld  be  d isc a r d e d  and 
fre sh  m ate r ia l p rep ared .
♦ ♦ T h e  p o ly o x y e th y len e  d e r iv a t iv e  o f so rb ita n  m o n o o lea te , p rocu red  from 
A t la s  P ow d er C om pany, W ilm ington, D e la w are .
♦  ♦ ♦ S u p ero x o l, M erck and C om pany, In c .,  R ah w ay , N ew  J e r s e y .
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temperature for 20 to 30 minutes; to this bacterial suspension 
is then added 0.5 ml. of the tween-peroxide mixture. The cata­
lase enzyme, if present and active, breaks down the hydrogen 
peroxide to water and nascent oxygen; the latter bubbles 
throughout the reaction mixture, and it is this bubbling that 
is recorded as a positive test. Reaction tubes which do not 
bubble immediately are observed for 20 minutes before dis­
carding. Studies in this laboratory have revealed that the most 
critical temperature-pH combinations for catalase studies are 
room temperature and 68° C. at pH 7.
At room temperature the acid-fast bacilli are catalase positive. 
Those strains which possess no catalase activity at room 
temperature should be suspected of being isoniazid resistant 
strains. By suspending organisms in phosphate buffer of pH 7 
and then placing them in a 68° C. water bath for 20 minutes, 
it is possible to selectively knock out the catalase activity of 
human and bovine strains regardless of virulence; at this 
temperature-pH combination, all other acid-fast bacilli (avian, 
saprophyte, and atypicals) are catalase positive.
5. The observation of acid production from carbohydrates is very 
helpful in the differential typing of rapid growing acid-fast 
saprophytes and M. fortuitum. The procedures for this test are 
adequately described by Gordon et al. (bibliography). The 
composition of the inorganic nitrogen base medium is as fol­
lows: (NH4)2HP04, 1 g.; KC1, 0.2 g.; MgS04, 0.2 g.; agar 15 
g.; distilled water 1000 ml. pH is adjusted to 7.0 and 15 ml. of
0.04 percent brom cresol purple added. The medium is put up in 
5 ml. amounts, sterilized by autoclaving (15 lb./15 min.), and 
prior to use 0.5 ml. of a 10 percent aqueous solution of the 
carbohydrate to be tested, sterilized by autoclaving, is added 
aseptically to each tube.
Strains of M. phlei are identified by acid production from glu­
cose, mannitol and sorbitol and usually from mannose and 
arabinose; no acid is produced from rhamnose, inositol or 
dulcitol. M. smegmatis ferments many sugars, producing acid 
from glucose, rhamnose, xylose, arabinose, sorbitol, inositol, 
mannose, mannitol, trehalose and galactose, and usually from 
dulcitol. Strains of M. fortuitum produce acid from glucose, 
mannose, trehalose, and occasionally mannitol. In our labora­
tory, acid is frequently produced from maltose. There is, how­
ever, no acid production from arabinose, sorbitol, inositol or 
dulcitol.
It can be seen that these sugar reactions are of considerable 
help in typing rapid growing acid-fast bacilli, and this typing is
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especially important in view of the fact that certain rapid 
growing bacilli are in fact, not saprophytes, but agents of 
disease in man.
There are other cytochemical tests that have been proposed for 
use in typing and virulence-testing of acid-fast bacilli. Many of 
these tests are referred to in the bibliography but are not 
described in detail in the context either because they are no 
longer considered reliable or because they haven’t been tested 
on sufficient numbers of cultures to warrant their inclusion 
in routine studies.
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Methods for Testing Sensitivity 
of Tubercle Bacilli to Therapeutic Agents
Sensitivity tests may be performed either by the direct method, 
using as inoculum the treated and concentrated primary clinical 
material such as sputum, or by the indirect method in which a portion 
of a previously isolated pure culture of the organism is the inoculum. 
The direct method has the advantage of saving time and of inocula­
ting the test medium with a bacterial population in which the propor­
tion of resistant and susceptible organisms is that existing in the 
exudate sampled. The exudate must contain, however, an adequate 
number of organisms so that clear and reliable differences between 
the growth appearing on the drug-containing tubes and the control 
tubes can be perceived. There should be at least 50 colonies on each 
of the control tubes. Furthermore, the organisms in this inoculum of 
treated clinical material must be evenly dispersed.
If the organisms present in the direct inoculum of processed clini­
cal material are so few as to render doubtful the significance of dif­
ferences between the tests and the controls, the test must be repeated 
using a pure culture of the bacilli isolated on a drug-free medium. 
The pure culture or “ indirect”  method allows the preparation of a 
standardized inoculum.
If the medium chosen for this work is one requiring inspissation 
and heat sensitive antibiotics are to be used, it becomes necessary 
to add the antibiotic, before inspissation, in sufficient quantity to 
allow for deterioration due to heat and at the same time insure the 
final desired effective quantity in the finished medium. Accuracy is 
difficult under these conditions and this laboratory has accordingly 
been accustomed for sometime to use a medium in which inspissation 
is not required. Herrold’s egg-yolk medium is used in this laboratory. 
If the specimen to be examined is one of primary clinical material, 
using the direct method, two additional control tubes of Lowenstein- 
Jensen medium without antibiotic are included in the series. Other 
media not requiring inspissation have been used with equally good 
results, e.g., the 7-H9 and 7-H10 media of Middlebrook (see appendix 
for formulae).
A. Suggested Procedures for Several of the More Commonly Used 
Antituberculous Drugs.
1. Streptomycin (SM):
a. Pathological specimens — clinical material.
1) Decontaminate and concentrate the clinical specimen or 
sample by the usual NaOH method.
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2) Using aseptic technique, mix the sediment well with 1.0 
ml. of sterile distilled water. The amount of water will vary 
with the number of tubes to be inoculated. Inoculate 0.1 
ml. of this treated and diluted sediment onto each tube of 
medium. Each set of media contains: 2 tubes of Herrold’s 
egg-yolk agar medium containing 10 and 100 meg., re­
spectively, of streptomycin per ml. of medium, 2 control 
tubes of Herrold’s medium without antibiotic, and 2 con­
trol t u b e s  of Lowenstein-Jensen medi um without 
antibiotic.
b. Cultures
If repeated tests of the antibiotic sensitivity of cultures of 
tubercle bacilli are to be comparable, it appears desirable 
that the inocula be standardized. A variety of methods is 
available for the standardization of suspensions of tubercle 
bacilli. One method which combines simplicity with a fair 
degree of accuracy is that involving the use of the Hopkins 
vaccine centrifuge tube. The technique for this procedure is 
given under Preparation of Cultures for Typing by Animal 
Inoculations, Steps 1 — 9. (see page 30).
1) From the standardized suspension prepare a culture 
dilution containing 10"2 mg./ml.
2) Using aseptic technique, mix well with a pipette and 
inoculate 0.1 ml. of the 10"2 suspension onto each tube of 
medium. The inoculum would be 10 "3 mg. or .001 mg. onto 
each tube. Each set of medium tubes contains: 2 tubes of 
Herrold’ s medium containing 10 and 100 meg. respectively, 
of streptomycin per ml. of medium, and 2 control tubes of 
Herrold’s medium without antibiotic. When pure cultures 
are used, it does not appear necessary to employ the more 
sensitive Lowenstein-Jensen medium for control.
c. Incubation
After the tubes have been inoculated, incubate at 37° C., 
leaving the inoculated tubes in the slanted position for 2 
weeks in order that growth may not be confined to the bot­
tom of the slant surface. Examine at the end of 2 weeks 
and each week thereafter until the cultures are 4 weeks 
old.
d. Reading and Reporting Results
The reporting of the results of the sensitivity tests is 
based upon the following reading procedures. (Table VI).
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TA BLE  VI
INTERPRETATION  OF DRUG SENSIT IV ITY TESTS
Growth in Tubes Report
Contro ls 10 meg./ml. 100 meg./ml.
Growth No Growth No Growth Sen sit ive  to 10 meg./ml.
Growth Growth (equal 
to controls)
No Growth R e s is tan t in 10 meg./ml. 
Sen sit ive  to 100 meg./ml.




R e sistan t in 100 meg./ml.
Growth Growth ( le ss  
than controls)
No Growth Partia lly  resistant in 
10 meg./ml.
Sen sit ive  to 100 meg./ml.
Growth Growth (equal 
to controls)
Growth ( le ss  
than controls)
R e s istan t in 10 meg./ml. 
Partia lly  resistant in 
100 meg./ml.
Although the written reports consist of appropriate phrases, selected 
from column four of the above table, the laboratory is advised to keep 
a record of the data upon which the reports have been based. A use­
ful supplement to this record may be made according to the following 
schedule:
If less than 25 percent of the surface is covered with growth, the 
colonies are actually counted.
If 25 to 50 percent of the surface is covered with growth, growth 
is recorded as 2+.
If 50 to 75 percent of the surface is covered with growth, growth 
is recorded as 3+.
If 75 to 100 percent of the surface is covered with growth, growth 
recorded as 4+.
2. Para-Aminosalicylic Acid (PAS):
The method of testing, reading, recording, and reporting for 
sensitivity to PAS is the same as described above for strepto­
mycin with the exception that the concentrations of sodium 
para aminosalicylic acid to be added to the medium are .001 
mg./ml., .01 mg./ml., and 0.1 mg./ml., respectively. Included 




The method of testing, reading, recording, and reporting for 
sensitivity to isoniazid is the same as that described for 
streptomycin and for PAS. The concentrations of isoniazid 
used are 0.2 meg./ml., 1 meg./ml., 5 meg./ml. of the finished 
medium. For cultures known or suspected to be resistant, a 
tube containing 10 meg./ml. of medium may be included in the 
test. The usual control tubes without the drug are included 
in the test.
4. Viomycin:
The method of testing, reading, recording, and reporting for 
sensitivity to viomycin is the same in principle as that used 
for the foregoing therapeutic agents. The concentrations used 
in the finished medium are 10 meg./ml., 50 meg./ml., and 100 
meg./ml., respectively. Each test includes the usual tubes of 
control media without the antibiotic.
5. Pyrazinamide (PZA):
The method of testing, reading, recording, and reporting of 
sensitivity to PZA is the same as that used for other drugs. 
The concentrations suggested in the Veterans Administration 
conference on chemotherapy of tuberculosis (1956) are 10 
meg./ml., 20 meg./ml., 40 meg./ml., 100 meg./ml., and 500 
meg./ml. of media. Solid media at pH 5.25 is recommended.
6. Cycloserine:
The preceding methods of testing apply also to cycloserine, 
using the following drug concentrations: 5 meg./ml., 10 meg./ 
ml., 20 meg./ml., and 50 meg./ml. of media.
It is recommended that all the above-named drug dilutions be 
made up just prior to incorporation in the medium; this is espe­
cially true for cycloserine which is unstable in solution. It is 
further recommended that cycloserine media be kept NOT longer 
than two weeks, due to its rapid deterioration and loss of 
potency.
B. Preparation of Medium and Dilutions of Therapeutic Agents
1. Modified Herrold’s Egg-Yolk Agar medium,
a. Agar Base:
Difco dehydrated nutrient agar 23 gm.
The above-named nutrient agar contains:










b) Dissolve ingredients by heating to 100° C., and distribute in 
150 ml. quantities in 250 ml. flasks.
c) Autoclave for 15 minutes at 15 lbs.(121° C.)
d) Cool to 47° C.
e) Add antibiotic or drug dilution just before adding the egg- 
yolk.
f) Add 50 ml. of eggyolk per flask just before tubing.* Mix 
well by rotating the flask.
g) Tube medium aseptically, 3 to 4 ml. per tube, and slant the 
tubes before the medium solidifies.
h) Incubate the tubes for 48 hours to test for sterility.
2. Preparations of Antibiotic or Drug Dilutions.
The first or pilot dilution of the therapeutic agent is made in 
distilled water and is sterilized by filtration through a bacte­
rial filter. Subsequent dilutions are made aseptically in sterile 
distilled water. It has been found that media containing the 
antibiotics streptomycin or viomycin will keep for at least 
8 weeks at 5 ° C.
a. Preparation of Streptomycin Dilutions:
1) Dissolve 0.2 gm. of streptomycin in 10 ml. of distilled 
water. Filter.
2) Dilute 1 ml. of 1) with 9 ml. of sterile distilled water. 
When added to 200 ml. of the finished medium
1 ml. of 1) gives 100 meg./ml. of medium.
1 ml. of 2) gives 10 meg./ ml. of medium.
b. Preparation of Sodium PAS Dilutions:
1) Dissolve 0.6 gm. of PAS in 3 ml. of distilled water. Filter.
2) Dilute 1 ml. of 1) with 9 ml. sterile distilled water.
3) Dilute 1 ml. of 2) with 9 ml. sterile distilled water.
4) Dilute 1 ml. of 3) with 9 ml. sterile distilled water.
♦ Scru b  fr e sh  e g g s  w ith so a p  an d  w a ter . R in s e .  P la c e  in  70 p e rce n t a lc o h o l for 
15 m in u tes . S e p a ra te  the e g g  y o lk s  and  w h ite s  a s e p t ic a l ly .  Mix the e g g  y o lk s  
u n til th e y  a re  h o m ogen eou s. N ote  th at the e g g  y o lk  i s  ad d ed  a f te r  m ed ia  h a s  
b e e n  s te r i l iz e d .  T h ere fo re  r ig id  a s e p t ic  p re c a u t io n s  a re  n e c e s s a r y .
When added to 200 ml. of the finished medium
1 ml. 1) gives 1 mg./ml. (100 mg. percent)
1 ml. 2) gives 0.1 mg./ml. (10 mg. percent)
1 ml. 3) gives 0.01 mg./ml. (1 mg. percent)
1 ml. 4) gives 0.001 mg./ml. (0.1 mg. percent)
c. Preparation of Isoniazid Dilutions:
1) Dissolve 10 mg. of isoniazid in 10 ml. of distilled water. 
Filter.
2) Dilute 1 ml. of 1) with 4 ml. of sterile distilled water.
3) Dilute 1 ml. of 2) with 4 ml. of sterile distilled water. 
When added to 200 ml. of finished medium
1 ml. 1) gives 5 meg./ml.
1 ml. 2) gives 1 meg./ml.
1 ml. 3) gives 0.2 meg./ml.
d. Preparations of Viomycin Dilutions:
1) Dissolve 0.2 gm. of viomycin in 10 ml. of distilled water. 
Filter.
2) Dilute 1 ml. of 1) with 9 ml. of sterile distilled water. 
When added to 200 ml. of the finished medium
1 ml. 1) gives 100 meg./ml. of medium
0.5 ml. 1) gives 50 meg./ml. of medium 
1 ml. 2) gives 10 meg./ml. of medium
e. Preparation of Pyrazinamide Dilutions:
1) Dissolve 1 gm. of Pyrazinamide in 10 ml. of distilled 
water at about 60° C. Filter.
2) Dilute 1 ml. of 1) with 4 ml. of sterile distilled water.
3) Dilute 1 ml. of 2) with 1.5 ml. of sterile distilled water.
4) Dilute 1 ml. of 2) with 4.0 ml. of sterile distilled water. 
When added to 200 ml. of the finished medium
1 ml. 1) gives 500 mcg./ml. of medium 
1 ml. 2) gives 100 mcg./ml. of medium 
1 ml. 3) gives 40 mcg./ml. of medium 
1 ml. 4) gives 20 mcg./ml. of medium 
0.5 ml. 4) gives 10 mcg./ml. of medium
f. Preparation of Cycloserine Dilutions:
1) Dissolve 0.1 gm. of cycloserine in 10 ml. of distilled 
water. Filter.
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2) Dilute 2 ml. of 1) with 3 ml. of sterile distilled water.
3) Dilute 1 ml. of 1) with 4 ml. of sterile distilled water.
4) Dilute 1 ml. of 1) with 9 ml. of sterile distilled water.
When added to 200 ml. of the finished medium
1 ml. 1) gives 50 meg./ml. of medium 
1 ml. 2) gives 20 meg./ml. of medium 
1 ml. 3) gives 10 meg./ml. of medium 
1 ml. 4) gives 5 meg./ml. of medium
Proper dilutions of any other drug may be readily 
calculated in a similar manner.
C. Inoculating “Spade:”
A satisfactory harvesting spade may be devised by flattening the 
end of a short inoculating needle of stiff wire with hammer and anvil.
S P A D E  — 18 gauge wire (nichrome)
Front V iew Side V iew
52
Appendix
A. Stains and Reagents
1. Ziehl-Neelsen Reagents:
a. Carbol Fuchsin:
Satuated solution of basic fuchsin 10 ml.
(10 gm. basic fuchsin in 100 ml. of 
95 percent ethyl alcohol)
5 percent aqueous solution of phenol 90 ml.
b. Acid Alcohol:
HCL (concentrated) 3 ml.
Ethyl alcohol 95 percent 97 ml.
c. Counter Stain:
Methylene Blue 0.3 gm.
Distilled water 100 ml.
2. Phenol Red Indicator (0.4 percent):
Stock solution: Dissolve 0.1 gm. of solid phenol red in 25 ml. 
N/20 NaOH. This may be stored in the dark.
3. 4 Percent NaOH Digestant:
Dissolve 40 gm. of NaOH in 1000 ml. distilled water. Add 1 ml. 
of phenol red indicator stock solution to every 99 ml. of NaOH 
digestant. This solution should be freshly prepared at least 
once a month. The digestant should be sterilized. This gives a 
0.004 percent concentration of phenol red.
4. 2 N HCI:
Dilute 167.2 ml. concentrated HCI up to 1000 ml. with distilled 
water. Distribute in 2 ml. quantities in screw-cap test tubes 
and sterilize.
5. Physiological Saline:
Dissolve 8.5 gm. NaCl in 1000 ml. distilled water.
B. Laboratory Equipment*
1. Inspissators:
a. Inspissator — Levin Model — constant temperature at 50° C. 
to 80 C. Holds 144 tubes — twice a day. Size: 30" x 14" 
x 10". Distributor: Will Corporation; Price: S375.00 (as of 
1958).
♦ T h is  d o e s  not n e c e s s a r i ly  c o n st itu te  an  en d orsem en t o f th e se  p ro d u c ts  by the U . S. 
P u b lic  H e a lth  S e rv ic e . P r i c e s  are  curren t and  a re  s u b je c t  to  ch a n g e .
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b. Inspissator — Coagulator “ Elconap”  #7530 — automatic 
electric, jacketed, constant temperature at 50° — 90° C. 
Size: 29" x 22" x 12". Holds 288 to 384 tubes twice a day. 
Distributor: Standard Scientific Supply Company, 34 W. 4th 
Street, New York 12, New York. Price: $396.00 to $528.00 
(1952).
c. U.S.P.H.S. inspissator — not commercial — holds 130 tubes 
per hour. The cost of materials and labor is from $500,000 to 
$700.00 (as of 1954).
d. Several laboratories are using the usual hot air sterilizer 
(size: 24" x 17" x 18" with 4" insulation) as an inspissator 
by placing a large pan of water on the bottom of the steri­
lizer and heating the sterilizer to 89° C. A large tray with a 
layer of towels on the bottom is filled with one layer of 
of slanted egg medium culture tubes (this tray holds approxi­
mately 90 tubes). The tray of tubes is placed in the hot air 
sterilizer 8 inches above the pan of water, and allowed to 
heat for 40 minutes. The temperature of the oven drops to 
32° C. when the tubes are first placed in the oven, but it 
gradually rises and remains at 89° C. for the last 10 min­
utes of inspissation. Using this method, good results in the 
texture, moisture content, sterility, and consistency of the 
medium have been obtained. Only a few tubes near the 
sides of the oven, where the temperature is irregular will 
need to be discarded. This procedure may be satisfactory, 
but an inspissator is preferable.
2. Paint Shaker:
Paint conditioner, laboratory model, Red Devil #34.
Holds '4-pint to 1-quart can.
No attachments or adjustments.
Obtainable from Red Devil Tools, Irvington, New Jersey.
Price: $60.00 (1954).
3. Paint-Shaker Can:
The can itself is 6" in diameter and 6*4" in height. The re­
movable inside rack, for holding 26 tubes (.16 mm. diam.), has 
two shelves. Each shelf is 5-7/8" in diameter and the entire 
rack is 5-1/8" in height. The can and rack are constructed of 
16-gauge metal, as is the removable lid. A disc of the same 
material, 4-3/8" in diameter is spot-welded to both lid and 
bottom in such a manner as to accommodate the adjustable 
clamps of the paint-shaker. Circular sponge rubber pads should 
be inserted above and below the rack in order to minimize 
breakage. (Can specially constructed)
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4. Splash Proof Can:
Can, stainless steel, rustproof; 6" in diameter x 3" in height. 
Can has a splash-proof lid made to fit 1" down on can. Lid 
constructed of stainless steel and hole in center 1%" in diame­
ter having a stainless steel funnel, 5" at top diameter tapered 
to 114" at bottom welded to center hole of lid. (Can specially 
constructed)
5. Discard Can:
Can constructed of #34 gauge stainless steel, to be rustproof 
and water-tight to withstand 250° to 300° F. Outside dimen­
sions 9JI x 10" long x 5" deep. Top hinged on piano hinge to 
overhang sides by a minimum of All seams soldered with 
50-50 solder and edges are finished smooth. (Can specially 
constructed)
6. Pipette Discard Trays:
Covered catheter trays. A. S. Aloe Company, St. Louis. (Hospi­
tal Supply Catalogue) or American Hospital Supply Corporation.
7. Slide Warmer:
Slide Warming Table — Ranson Electric (Cat. No. 19646). Can 
be bought from Will Corporation, Rochester 3, New York.
8. Cornwall Pipetting Unit:
No. 1251 — containing Cornwall syringe, double valve, S1^ " 
stainless cannula, 20" amber rubber tubing with metal sinker. 
Can be obtained from Becton, Dickinson and Company, Ruther­
ford, New Jersey.
9. Caulfield Pipettor:
Pipette control safety bulb — Aloe No. 69300, St. Louis 
Missouri.
10. Hand Lens:
Magnifiers, Coddington, Folding (Cat. No. 17541) 10X or 14X 
magnification-. Can be obtained from Will Corporation, Rochester 
3, New York, or Hastings Triple Aplanot, 10X or 14X, A. S. Aloe 
Company, St. Louis, Missouri
11. Luer-Lok Syringes (Becton-Dickenson):
These syringes prevent accidental separation of syringe and 
needle. Any laboratory supply company.
12. Culture Tubes:
Kimball Brand — screw cap — 20 x 150 mm. Size D 
Aloe No. 78290 or Kimball #45066.
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13. Centrifuge Tubes:
Bacteriological culture tubes, screw capped (Kimball No. 
45066) 125 mm. in length, 16 mm. outside diameter. Can be 
obtained from Will Corporation, Rochester 3, New York.
14. Avian Tuberculin:
Can be obtained from veterinary supply house.
15. Potato Flour:
Can be obtained from J . M. Henson Bakery Supplies, 500 
Stewart Ave. S.W., Atlanta, Georgia, or any bakery supply 
company.
16. Spade:
A spade may be made by flattening the end of a nichrome wire 
(18 gauge). The flattened area should be 5 to 10 mm. long 
by 0.5 mm. thick.
S P A D E  -  18 gauge (Nichrome)
Front V iew Side V iew
C. Culture Media
1. Modified Lowenstein’s Medium:
Salt Solution:
Monopotassium Phosphate (anhydrous).................. 2.4 gm.
Magnesium sulfate 7H20 .........................................  0.24 gm.
Magnesium citrate....................................................  0.6 gm.
A sparagine................................................................  3.6 gm.
Glycerol (reagent grade) ......................................  12.0 ml.
Distilled water........................................................... 600.0 ml.
Potato F lour...................................................................  30.0 gm.
Homogenized whole e g g s ............................................. 1000.0 ml.
Malachite green, 2 percent aqueous solution.............  20.0 ml.
30 gm. of potato flour is added to the flask of salt solution and 
the mixture is autoclaved at 121° C. for 30 minutes.
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Fresh eggs, not more than 1 week old, are employed and cleaned 
by vigorous scrubbing in an approximately 5 percent soap solu­
tion. They are left in the soap solution for 30 minutes, and are 
then placed in running cold water, until the water becomes 
perfectly clear. They are then immersed in 70 percent alcohol 
for 15 minutes. They are broken into a sterile flask, homoge­
nized completely by shaking, and filtered through 4 layers of 
sterile gauze.
One liter of homogenized whole eggs is added to one flask of 
the potato flour-salt solution, which has been cooled to room 
temperature, and to this is added 20 ml. of malachite green. 
The medium is thoroughly mixed.
The medium is tubed by means of a sterile aspirator bottle, 
or funnel, with bell attachment, or similar tubing device. 
Between 5 and 6 ml. is delivered into 150 mm. pyrex test tubes, 
and these tubes are solidified by inspissation at 85° C. for 
50 minutes. The medium is then checked for sterility by incu­
bation at 37° C. for 48 hours.
It is advisable to keep the medium stored in a refrigerator. 
This will keep for at least 1 month in the refrigerator, if 
the tubes are tightly closed to prevent evaporation.




Peptone. . . .
Diced potato
Heat in double boiler 1 hour, stirring constantly.
MIXTURE B
E g g s .......................................................................  8.0 (whole)
Glycerol (reagent grade)..........................................18.0 ml.














Mix A, B, and C in a sterile flask and strain through one layer 
of gauze. Tube and sterilize in slanting position. Sterilize 
by inspissation for 1 hour at 80° C.
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3. Trudeau Committee Medium (A.T.S.)
Egg yolk.......................................................................  500.0 ml.
Potato flour water (2 percent glycerine)................  500.0 ml.
a. The potato flour water is made by adding 20 gm. potato 
flour to 500 ml. of 2 volume percent glycerol water in a flask. 
Heat to boiling with constant stirring. Cool to 50° C.
b. Egg yolk: Fresh hen eggs are carefully cleaned with wet 
gauze, rinsed in alcohol, and flamed. The egg white and 
yolks are separated. A proportion of one whole egg to eleven 
egg yolks is used and 500 ml. of this c o mb i n a t i o n  is 
prepared.
c. The 500 ml. of egg yolks are poured into the 500 ml. of 
potato flour water and to this is added 20 ml. of 1 percent 
malachite green solution in 50 percent alcohol. All ingre­
dients are thoroughly mixed and tubed.
d. The medium is coagulated in a slanted position and steril­
ized by a single one-hour inspissation at 90° C.
4. Peizer’s Medium
a. Agar Base:
Bacto beef extract 3.0 gm.
Casein hydrolysate
(Difco Casamino Acids) 10.0 gm
Potato starch 15.0 gm
Bacto asparagin 3.0 gm
Dipotassium phosphate 3.5 gm
Ferric ammonium citrate 0.1 gm
Citric acid 0.1 gm
Magnesium sulphate 0.015 gm
Bacto agar 15.0 gm
Distilled water 1,000.0 ml
Add all the ingredients except the starch and agar to 480 ml. 
of distilled water, cover, and boil slowly for 15 minutes over 
a small bunsen flame. Dissolve the potato starch in 50 ml. 
of cold distilled water and stir slowly into the boiling solu­
tion. Continue stirring and boiling the solution for approxi­
mately 3 minutes to cook the starch. Add distilled water to 
bring the volume up to 500 ml. and place the covered con­
tainer of starch mixture in the Arnold sterilizer to steam for 
1 hour. At the same time melt the agar-agar which has been 
added to 500 ml. of distilled water in the Arnold sterilizer
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for 1 hour. Next, mix the starch solution and the melted agar. 
Dispense in convenient amounts and sterilize in the auto­
clave for 10 minutes at 15 lbs.
One liter of this agar base, melted and cooled to 55° C. may 
be enriched with either one of the two following enrichment 
mixtures:
b. Enrichment Mixture:
1) 10 egg yolks (separated aseptically)
25 ml. sterile saline
40 ml. sterile glycerol (reagent grade)
13 ml. sterile 1 percent malachite green 
1 ml. sterile 20 percent dextrose
Shake the yolks well with the saline before adding the 
glycerol and the malachite green. The enrichment mixture 
must be well shaken before adding to the melted agar 
which has previously been cooled to 55° C.
or
2) 5 sterile egg yolks (separated aseptically)
30 ml. sterile sodium oleate
36 ml. sterile 1 percent malachite green
Shake well to mix before adding to the melted agar, pre­
viously cooled to 55° C.
The enriched agar is tubed with aseptic precautions in 
screw-cap tubes in about 8 ml. quantities. The tubes are 
then slanted, leaving a butt of at least 1 inch. The tubes of 
medium are incubated for 24 hours to test for sterility.
5. Dubos-Middlebrook Media (Tween-Albumin Broth and Oleic
Acid-Albumin Agar):
a. Basal Medium:
Potassium acid phosphate (KH2P 04) ............................1.0 gm.
Dibasic sodium phosphate (Na2HP04.12H20 ) ........... 6.3 gm.
(or 2.5 gm. of the anhydrous Na2HP04)
. . (for liquid media)...........
AsparaglnC................... (for solid m edia)............





Distilled water 850 ml.
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Enzymatic digest of
casein or Casitone (for liquid m edia)................  2 gm.
(for solid media) ................  1 gm.
Ferric Ammonium citrate (for liquid media) . . 0.05 gm.
(for solid media) . . 0.005 gm.
Magnesium sulfate (MgSO 4.7H20 ) ................... 0.01 gm.
(1 ml. of 1% stock solution 
in distilled water)
Calcium chloride (CaCl2) .................................  0.0005 gm.
(1 ml. of 0.05% stock solution 
in distilled water)
Zinc sulfate (ZnS04) .........................................  0.0001 gm.
(1 ml. of 0.01% stock solution 
in distilled water)
Copper sulfate (CuS04) .................................... 0.0001 gm.
(1 ml. of 0.01% stock solution 
in distilled water)
Adjust pH to 6.5-6.8 with HC1
b. For liquid Tween-albumin media
Basal Medium............................................................  900 ml.
Tween 80   0.5 ml.
(or 5 ml. of 10% stock solution 
in distilled water)
Autoclave, cool to 56° C.
ADD:
Bovine albumin fraction V .............................. 5 gm.
(100 ml. of 5% stock in 0.85% 
saline neutralized with NaOH 
and sterilized by Seitz filtration))
G lu c o se ...............................................................  5 gm.





c. For Oleic acid-albumin agar
Use only:
1 gm. of asparagine 
1 gm. of enzymatic digest of casein 
0.005 gm. of ferric ammonium citrate
Basal medium...............................................................  900 ml.
Agar ............................................................................. 11.0 gm.
Autoclave, cool to 56° C.'
ADD: 100 ml. of the following oleic acid albumin complex.
(1) Dissolve 0.12 ml. (0.1 gm.) of oleic acid in 10 ml. of 
N/20 NaOH by shak’ing with rotary motion in small flask.
(2) Add 5 ml. of this to 95 ml. of neutral 5 percent solution 
of bovine albumin fraction V in 0.85 percent saline.
(3) Sterilize by filtration through bacteriological filters, 
either glass or Seitz.
Dispense as desired.
6. Tarshis Blood Agar
Plain A g a r ..................................................................... 1.5 gm.
Glycerol (analytical grade)........................................  1.0 ml.
Human bank blood (with ACD solution*)......................30.0 ml.
Distilled water ...............................................................69.0 ml.
Penicillin (50 to 100 units/ml.)
Final pH 6.8
Agar is dissolved in glycerol-water by heating. 
Autoclave at 121° C./15 min. Cool to 45° C. and 
add penicillin and blood.
*ACD solution has the following composition:
Citric acid. . . 
Sodium citrate 
Glucose
? o7 \ Per 100 ml. of trans- 
fusion solution.2.45 gm.)
7. Middlebrooks 7-H3 Medium
KH2P 0 4 ...............................................................  1.0 gm.
1 — glutamate (Na s a l t ) .................................... 0.5 gm.
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*Glycerol (reagent grade).................................... 2.0 ml.
Ferric ammonium citrate.................................... 0.1 gm
CaCl2.2H20 .........................................................  0.0005 gm
CuS0 4.5H20  ....................................................... 0.001 gm
Ca pantothenate.................................................  1.0 mgm
Na2HP04.12H20 .................................................  6.3 gm
Ammonium sulfate............................................... 0.5 gm
Nag citrate.2H20 ............................................... 0.1 gm
MgS04.7H20  ..............................................  0.05 gm
ZnS04.7H20  ............................................... 0.001 gm
Pyridoxine.HCl ............................................... 1.0 mgm
B io t in .................................................................. 0.5 mgm
Vitamin free casein hydrolysate........................ 0.1 gm
*Omit glycerol if Tween 80 is used in liquid 
Dissolve in 100 ml. of distilled water. Adjust to pH 6.6.
a. For liquid medium:
Before autoclaving, add Tween 80 in final concentration 
of 0.05 percent and after autoclaving (12PC./15 min.) cool 
to 56 ° C. and add bovine albumin fraction V in final concen­
tration of 0.5 percent.
b. For solid medium:
Before autoclaving, add agar in final concentration of 1.5 
percent and 1 meg./ml. of malachite green (Coleman and 
Bell). After autoclaving add oleic acid-albumin complex in 
final concentration of 0.5 percent.
Oleic acid albumin made as follows: Dissolve 0.12 ml. of 
oleic acid in 10 ml. of N/20 NaOH by shaking with rotary 
motion in small flask. Add 5 ml. of this to 95 ml. of neutral 
5 percent solution of bovine albumin in 0.85 percent saline. 
Sterilize by filtration.
After autoclaving, add to ALL media 0.2 percent final con­
centration of glucose from a sterile concentrated stock 
solution.






1- glutamate (Na s a l t ) .........................................
(20 ml. of 2.5 percent solution)
. 0.5 gm.
Ammonium sulfate ...............................................
(20 ml. of 2.5 percent solution)
. 0.5 gm.
Glycerol (reagent grade)......................................
(omit if Tween is used in inocula)
. 2.0 ml.
Na 3 citrate. 2H 20 ....................................................
(1 ml. of 10 percent solution)
0.1 gm.
Fe ammonium citrate (green)..............................
(0.4 ml. of 10 percent solution)
. 0.04 gm.
MgSO 4.7H 20  .......................................................
(5 ml. of 1 percent solution)
. . 0.05 gm.
CaCl2 ....................................................................
(0.5 ml. of 0.1 percent solution)
. . 0.0005 gm.
ZnS04.7H20  .......................................................
(1 ml. of 0.1 percent solution)
. . 0.001 gm.
CuS 0 4.5H20  .......................................................
(l ml. of 0.1 percent solution)
. . 0.001 gm.
Pyridoxine H C 1 ....................................................
(1 ml. of 0.1 percent solution)
. . 1.0 mgm.
B io t in ....................................................................
(0.25 ml. of a 2 mg./ml. solution)
. . 0.5 mg
Dissolve above, in order given, in 900 ml. distilled water.
Adjust pH to 6.6 with 10 percent HC1 (about 5 ml./liter 
of base medium)
For inhibition of contaminants add 1 mcg./ml. of malachite 
green oxalate.
Add purified agar (Baltimore Biological or Difco) to 1.5 
percent.
Autoclave
Cool to 45°-50° C. and add:
Oleic acid-albumin complex to 0.5 percent
Glucose................................. to 0.2 percent
C a ta la se ............................... to 3 mcg./ml.




Fe ammonium citrate.................................  0.4 gm.
Na3 citrate.2H20 ......................................  4.0 gm.
Ammonium sulfate......................................  5.0 gm.
L-glutamic acid (Na s a l t ) ......................... 5.0 gm.
Na2HP04 (anhydrous)..............................  15.0 gm.
KH2P 0 4 (anhydrous).................................  15.0 gm.
45 gm.
Store above at room temperature after mixing and indicate on 
label that 0.45 gm. will make up to 100 ml. with distilled 
water at pH 6.6, if 1.5 gm. Baltimore Biological agar is 
used/100 ml.
Heat-labile solution (filter-sterilized) -1 tube (13.5 ml.) to be 
added to each 100 ml. of above agar base after autoclaving 
agar base:
Oleic acid-albumin complex (5 percent). . .10.0 ml.
G lycerol...............................................................0.5 ml.
50 percent g lu c o se ........................................... 0.4 ml.
Pyridoxine-HCl (100 meg./ml.)........................1.0 ml.
Biotin (50 m eg./m l.)......................................... 1.0 ml.
Malachite green (100 m eg./m l.)................... 1.0 ml.
Catalase, technical (1000 m eg./m l.)........... 0.3 ml.
64
Bibliography
G e n e ra l R e fe r e n c e  B o o k s
American College of Chest Physicians. Fundamentals of Pulmonary Tubercu­
lo sis . Springfield, 111., Charles C. Thomas Co., 1949 
Calmette, A: Tubercle Bacillus Infection and Tuberculosis in Man and Animals.
Baltimore, Williams and Wilkins Co., 1923.
Canetti, G.: The Tubercle Bacillus in the Pulmonary Lesions of Man. New York, 
Springer Publishing Company, Inc., 1955.
Ciba Foundation Symposium on Experimental Tuberculosis, Bacillus and Host. 
Boston, Little, Brown and Co., 1955.
Darzins, E.: The Bacteriology of Tuberculosis. Minneapolis, University of Min­
nesota P ress, 1958.
Drea, W. F ., and Andrejew: The Metabolism of the Tubercle Bacillus. Springfield, 
111., Charles C. Thomas Co., 1953.
Finch, W. E.: Disinfectants, Their Values and U ses. New York, The MacMillen 
Co., 1958.
Francis, J . :  Tuberculosis in Animals and Man. London, C assell and Company, 
Lmtd., 1958.
Long, E. R.: The Chemistry and Chemotherapy of Tuberculosis. Baltimore, 
The Williams and Wilkins Co., 1958.
Pinner, M.: Pulmonary Tuberculosis in the Adult. Springfield, 111., Charles C. 
Thomas,Co., 1945.
Pottenger, F. M.: Tuberculosis. St. Louis, C. V. Mosby Co., 1948.
Rich, A. R.: The Pathogenesis of Tuberculosis. Springfield, 111., Charles C. 
Thomas Co., 1946.
Soltys, M. S.; Hill, C. S. St.; and Ansell, I.: Tubercle Bacillus and Laboratory 
Methods in Tuberculosis. Edinburgh & London, E. & S. Livingston Ltd., 1952. 
(Distributed in U. S. A. By Williams & Wilkins Company, Baltimore, Md.)
Wells and Long: The Chemistry of Tuberculosis. Baltimore, Williams and Wilkins 
Co., 1932.
Willis, H. S., and Cummings, M. M.: Diagnostic and Experimental Methods in 
Tuberculosis. Springfield, 111., Charles C. Thomas Co., 1952.
D ig e st io n , D eco n tam in a tio n  an d  C o n ce n tra tio n
Balmer, H. F ., and Ameson, G. A.: A combined concentration method for tuber­
cle bacilli. Amer. J .  Clin. Path. 17, 71, 1947.
Beattie, M.: Cultivation of M y co b acteriu m  t u b e r c u lo s is .  A comparison of hydro­
chloric acid and trisodium phosphate in the preparation of sputum and the use 
of fluid Dubos-Davis medium and Petragnani medium. J .  Lab. & Clin. Med. 
34(6): 733, 1949.
Cameron, G. M., and C astles, R.: Chlorox digestion. Am. Rev. Tuberc. 52:530, 
1935.
Collins, C. H.: Oxalic acid and acid-iron-peroxide in the routine culture of 
tubercle bacilli from sputum. Tubercle, 33(5): 149, 1952.
Cooke, and Giordane, A. S.: Relative value of concentration methods of sputum 
and gastric contents for the detection of acid fast bacilli. Am. J .  Clin. Path. 
Tech. Sect. pp. 15-94, 1945.
Corper, H. J . ,  and Nelson, C. R.: Methods of concentrating acid-fast bacilli. 
Am. J .  Clin. Path. 19:269, 1949.
Corper, H. J . ,  and Stoner, R. E.: An improved procedure for the diagnostic cul­
ture of mammalian tubercle bacilli. J . Lab. & Clin. Med. 31:1364, 1946.
Corper, H. J . ,  and Uyei, N.: The isolation of tubercle bacilli from contaminated 
tuberculous materials. Am. Rev. Tuberc. 16:299, 1927.
Corper, H. J .,  and Uyei, N.: Oxalic acid as a reagent for isolating tubercle 
bacilli and a study of the growth of acid-fast non-pathogens on different
65
mediums with their reactions to chemical reagents. J .  Lab. & Clin. Med. 
15:348, 1930.
Felsen, J . :  A method for detecting sparsely distributed tubercle bacilli. Arch. 
Path. 10:110, 1930.
Freiman, D. G., and Pinner, M.: Routine examination of sputum for acid-fast 
bacilli. Am. Rev. Tuberc. 59:449, 1949.
Gifford, D.; McKenley, F.; and Hunter, C. A.: A comparative study of methods 
of isolating M y co b acteriu m  t u b e r c u lo s i s . Am. J .  Pub. Health 41:164, 1951.
Hambleton, A.: Potential danger to laboratory workers of the trisodium phosphate 
method in the diagnostic culture of tubercle bacilli. Am. J .  Med. Technol. 
23:181, 1957.
Hanks, J .  H.; Clark, H. F.; and Feldman, H.: Concentration of tubercle bacilli 
from sputum by chemical flocculation methods. J .  Lab. & Clin. Med. 23:736, 
1938.
Hanks, J .  H., and Feldman, H. A.: Study of demonstration of tuberculosis in 
urine, by means of phosphate flocculation. J .  Lab. & Clin. Med. 25:974- 
980, 1940.
Hawirko, R. Z., and Murray, E. G. D.: Oil partition for the collection of small 
numbers of tubercle bacilli from aqueous suspensions. Canad. J .  Pub. Health 
45:208, 1954.
Holloway, J .  B ., and Cummings, M. M.: An evaluation of a method of obtaining 
gastric washings. Am. Rev. Tuberc. 60:228, 1949.
Kelso, R. E ., and Galbraith, T. W.: A rapid simple technic for detection of acid- 
fast bacilli in urine. Am. J . Clin. Path. Tech. Suppl. 7:8-11, 1948.
Keningale, J .  A.: The problem of contamination in routine cultural methods for 
M. t u b e r c u lo s i s .  The Bulletin of the Institute of Medical Laboratory Tech­
nology (London) 14(10):159, 1949.
Kibler, P ., and Lundholm, R.: Culture of tubercle bacilli from specimens of 
gastric juice. Am. J .  Clin. Path., 19:685, 1949.
Klein, G. C., e t a l .: Efficacy of centrifugation as a method of concentrating 
tubercle bacilli. Am. J .  Clin. Path. 22:581-585, 1952.
Lockard, C. D.: Recovery of M y co b acteriu m  t u b e r c u lo s is  from sputum or gastric 
washings. Am. J .  Clin. Path. 17:91, 1947.
Mitchell, R. B.; Je feries, M.; and Stucker, C. L .: The cultural diagnosis of 
tuberculosis in a public health laboratory. Pub. Health Lab. 6:32, 1948.
Mullahy, M. E.: Detection of acid-fast bacilli. Use of sodium hydroxide and tri­
sodium phosphate as digestants in preparing specimens. Am. J .  Clin. Path. 
20(7): 67 2, 1950.
Palen, M. I.; Wong, H. Y.; and Leifson, E .: Detection of M y co b acteriu m  tu b e rcu ­
l o s i s  in sputum by pepsin digestion and interface concentration with pentane. 
Am. Rev. Tuberc. 75:148, 1957.
Patterson, R. A.; Thompson, T. L .; and Larsen, D. H.: The use of zephiran in 
the isolation of M. t u b e r c u lo s i s . Am. Rev. Tuberc. 74:284, 1956.
Patterson, R. A.: A new method for the isolation of M. t u b e r c u lo s i s .  Am. J .  Pub. 
Health 46:1429, 1956.
Peizer, L . R.; Chaves, A. D.; and Widelock, D.: A trisodium phosphate transport- 
digestion method of processing sputum and gastric specimens for the detection 
of M y co b acteriu m  t u b e r c u lo s i s .  Am. Rev. Tuberc. 70:366, 1954.
Rappaport, F ., and Rosenknopf, D.: Improved concentration methods for bacteria, 
including tubercle bacilli. Am. J .  Clin. Path. 18:579, 1948.
Roberts, E. G.; Wallace, J .  L ; and Erlick, H.: Methods for isolating tubercle 
bacilli. Am. Rev. Tuberc. 61(4):563, 1950.
Robinson, L ., and Stovall, W. D.: Factors influencing the demonstration of tuber­
cle bacilli by concentration methods. J .  Lab. & Clin. Med. 27:84, 1941.
Saxholm, R.: Experiments with a new culture method for tubercle bacilli. Am. 
Rev. Tuberc. 69(2):305, 1954.
Saxholm, R.: Further experiments with combinations of pancreatin and quater­
nary ammonium compounds for cultivation of M y co b acteriu m  t u b e r c u lo s is .  
Am. Rev. Tuberc. 72:98, 1955.
66
Saxholm, R.: Pretreatment of sputum with enzymes and quaternary ammonium 
compounds for slide cultivation of tubercle bacilli. Acta path, et microbiol. 
scandinav. 37:132, 1955.
Saxholm, R.: Cultivation of M. t u b e r c u lo s is  from urine and gastric lavage by the 
pancreatin-quaternary ammonium compound method. Am. Rev. Tuberc. 74:616, 
1956.
Schain, P .; Magdalin, S.; and Russo, A.: A comparative study of several con­
centration methods. Quar. Bull. Sea. View Hosp. 7, 99, 1942.
Schain, P. S.; Magdalin, S.; and Russo, A.: Sputum examination. A comparative 
study of the chlorox and Tergitol-Javelle water concentration methods. Am. 
Rev. Tuberc. 57(6):640, 1948.
Schwarting, V.: The action of gastric contents on tubercle bacilli. Am. Rev. 
Tuberc. 58:123, 1948.
Sirsi, M.: A study on the methods of isolation and culture of M y cob acteriu m  
t u b e r c u lo s is .  Current Sci. 19( 10): 316, 1950.
Spendlove, G. A.; Cummings, M. M.; and Patnode, R. A.: Toxicity of sputum 
digestants to tubercle bacilli in water and sputum. Am. Rev. Tuberc. 60:628, 
1949.
Steenken, W., and Smith, M. M.: Culture of tubercle bacilli. Am. Rev. Tuberc. 
43:2, 1941.
Steenken, W., and Smith, M. M.: A shaking machine and containers for shaking 
sputums and other body fluids during the process of homogenization. J .  Lab. 
& Clin. Med. 27:1582, 1942.
Steenken, W.: Demonstration of tubercle bacilli. Am. Rev. Tuberc. 42:543, 1940.
Tarshis, M. S., and Lew is, W. G.: Use of chlorox and trisodium phosphate in the 
demonstration of acid-fast bacilli in sputum. Am. J . Clin. Path. 19:693, 1949.
Tonge, J .  I., and Hughes, P. G.: A comparative study of laryngeal swabs and 
gastric lavage in the detection of tubercle bacilli. Am. Rev. Tuberc. 73:930, 
1956.
Uhlenhuth and Xylander: Antiformin, ein bakterienauflosendes Desinfektions- 
mittel. Berl. Klin. Wchnschr. 45:134, 1908.
Van Vranken, M.: Diagnostic culture of tubercle bacilli. Am. Rev. Tuberc. 55: 
374, 1947.
Webb, C. R., e t a l . t  The efficiency of centrifugation as a means of concentrating 
tubercle bacilli from sputum. Am. Rev. Tuberc. 76:899-901, 1957.
Yegian, D., and Budd, V.: Toxic effect of sodium hydroxide on tubercle bacilli. 
Am. J .  Clin. Path. 22(5):456, 1952.
Roth, W., and Birkhauser, H.: Die Pufferung des Magensaftes bei der unter- 
suchung auf Tuberkelbazillen. Schweizerische Med. Wochenschrift 83:240, 
1953.
M ic ro sc o p y  an d  S ta in in g
Alexander-Jackson, E.: A differential triple stain for demonstrating and studying 
non-acid-fast forms of the tubercle bacillus in sputum, tissue, and body fluids. 
Science 99:307, 1944.
American Trudeau Committee: Fluorescent microscopy. Am. Rev. Tuberc. 50: 
465, 1944.
Berg, J .  W.: Chemistry of acid-fastness. Proc. Soc. Exper. Biol. & Med. 84:196, 
1953.
Berg, J .  W.: The dual nature of acid-fastness. Yale J .  Biol. & Med. 26:215, 1953.
Briggs, G. O. A., and Jennison, M. H.: Fluorescence microscopy and the modi­
fied Ziehl-Neelsen technique. Tubercle, 29:252, 1948.
Cooper, F. B.: A modification of the Ziehl-Neelsen staining method for tubercle 
bacilli. Arch. Path. & Lab. Med. 2:382, 1926.
Darrow, M. A.: Staining the tubercle organism in sputum smears. Stain Tech. 
24:93, 1949.
Ebina, T., et a l .; Morphological changes of tubercle bacilli caused by staining 
procedures. Nature 180:42-43, 1957.
67
Grasham, C.: Fluorescent microscopy. Am. J .  Clin. Path. 9:39, 1945.
Gross, M.: Rapid staining of acid-fast bacteria.Am. J .  Clin. Path. 22:1034, 1952.
Hallberg, V.: New method of staining tubercle bacilli (Nachtblau). Acta med. 
scandinav. P. 1, Supplement 46, 1939.
Hanks, J .  H.: Retention and differentiation of carbol-fuchsin-stained mycobacteria 
in diagnostic films. Am. Rev. Tuberc. 74:597, 1956.
Hanks, J .  H.: Retention and differentiation of mycobacteria in tissue sections. 
Am. Rev. Tuberc. 74:608, 1956,
Koch, R.: Die Aetiologie der Tuberculose. Berlin Klin. Wchenschr. 19:221,1882.
Kuroda, 0 . :  A new staining method for tubercle bacilli. J . Japan M. A. 28:232, 
1952. (Am. Rev. Tuberc. 67(5): 113, 1954).
Lack, C. H., and Tanner, F .: The significance of pleomorphism in M yco. tu b er­
c u lo s i s  var. h o m in is . J .  Gen. Microbiol. 8:18, 1953.
Lack, C. H.: The malachite green-safranin stain. Tubercle 39:125-126, 1958.
Lamanna, C.: The nature of acid-fast stain. J .  Bact. 52:99, 1946.
Lee, H. I.: Comparison of procedures for staining tubercle bacilli in fluorescence 
microscopy. J .  Lab. & Clin. Med. 29:218, 1944.
Lind, H. E.: Limitations of fluorescent microscopy for the detection of acid-fast 
bacilli. Am. J .  Clin. Path. 19:72, 1949.
Massen, W., and Knothe, H.: The staining of tubercle bacilli in sputum with 
soda fuchsin. Deutsche med. Wchnschr. 74:153, 1949.
Matsuoka, T ., and Nakajima, M.: The new method of staining tubercle bacillus 
and its biological and clinical significances. Ann. of Tuberc. 6:33-39, 1955.
Matthaei, E.: Simplified fluorescence microscopy of tubercle bacilli. J .  Gen. 
Microbiol. 4:393, 1950.
Moran, T. J . ;  Radcliffe, M. L .; and Tevault, I. H.: Rapid method of staining 
tubercle bacilli with Tergitol #7. Am. J .  Clin. Path. 17:75, 1947.
Muller, H. E ., and Chemock, R. L .: A rapid staining technique for acid-fast 
organisms. J .  Lab. & Clin. Med. 30:169, 1945.
Murohashi, T ., and Yoshida, K.: Improvement of malachite green-fuchsin staining. 
Acta, tuberc. scandinav. 36:195-98, 1958.
Pottenger, J .  E .: Controlled staining of M y co b ac te riu m  t u b e r c u lo s i s .  Am. Rev. 
Tuberc. 45:497, 1942.
Pottenger, J .  E .: Present practice in staining M y co b acteriu m  t u b e r c u lo s is  in 
representative institutions. Am. Rev. Tuberc. 45:568, 1942.
Pottenger, J .  E .: Counterstains in demonstrating M y co b acte riu m  t u b e r c u lo s is
in sputum. Am. Rev. Tuberc. 45:558, 1942.
Richards, 0 . WtJ and Kline, E. K.: Demonstration of the tubercle bacilli by 
fluorescent microscopy. Am. Rev. Tuberc. 44:255, 1941.
Schulte, T. H.: Zur Tuberkelbazillen Farbung. Deutsche med. Wchnschr. XIVI: 
1225, 1920.
Thompson, L .: Comparison of carbol fuchsin with the fluorescent dye auramine 
for the demonstration of acid-fast bacteria. Proc. Staff Meeting of Mayo Clin. 
16:673, 1941.
Tomasello, S. A., and Altabach, H.: Staining tubercle bacilli in tissue and smear, 
employing aerosol 0 . T. Am. J .  Clin. Path. 17:73, 1947.
Wollenman, 0 . J . ;  Montgomery, P. 0 . B.; and Foard, Z. B.: Acid-fast non- 
tubercle bacilli in paraffin. Am. J .  Clin. Path. 21:295.
Yegian, D., and Baisden, L .: Factors affecting and beading of the tubercle 
bacillus by the Ziehl-Neelsen technique. J .  Bact. 44:667, 1942.
Yegian, D., and Kurung, J . :  Morphology of the M y co b acteriu m  t u b e r c u lo s i s :  A 
study of the artefacts produced in smears. Am. Rev. Tuberc. 56:36, 1947.
Yegian, D., and Vanderlinde, R.: The nature of acid-fastness. J .  Bact. 54: 
777, 1947.
Yegian, D., and Porter, K. R.: Some artefacts encountered in stained preparations 
of tubercle bacilli. I. Non-acid-fast forms arising from mechanical treatment. 
J . Bact. 48:83, 1944.
Yegian, D., and Budd, V.: Ziehl-Neelsen Technique — staining properties modi­
fied by different preparations of basic fuchsin. Am. Rev. Tuberc. 48:54,1943.
68
Ziehl, F .: Zur Farbung des Tuberkelbazillus. Deutsch. med. wchnschr. 33: 
451, 1882.
C u ltu re  M ed ia
American Trudeau Society: Report of the Committee on Evaluation of Laboratory 
Procedures. Am. Rev. Tuberc. LIV:4, 1946.
Berry, J .  W., and Lowry, H.: A slide culture method for the early detection and 
observation of growth of the tubercle bacilli. Am. Rev. Tuberc. 60:51, 1949. 
Boissevain, C. H.: Growth promotion of the tubercle bacillus by serum albumen.
Proc. Soc. Exper. Biol. & Med. 44:110, 1940.
Clark, M. E .: Human plasma and blood agar for cultivation of tubercle bacilli. 
Am. J .  Clin. Path. 23:671, 1953.
Colwell, C. A., and H ess, A. R.: The effect of inspissation and storage on 
isoniazid concentrations in culture media. Am. Rev. Tuberc. 75:678, 1957. 
Corper, H. J . :  The cultivation of recently isolated and laboratory strains of human 
tubercle bacilli on artificial media. Am. Rev. Tuberc. 3:461, 1919.
Corper, H. J .,  and Cohn, M. L .: Combination egg media for the diagnostic culture 
of tubercle bacilli. Am. Rev. Tuberc. LIIl:575-582, 1946.
Corper, H. J .,  and Cohn, M. L .: Media for tubercle bacilli: An evaluation of 
different media for diagnostic cultures of tubercle bacilli. Am. Rev. Tuberc. 
46:560, 1942.
Corper, H. J . ,  and Cohn, M. L .: Nutrient quality of eggs for growing tubercle 
bacilli. Am. J .  Hyg. 18:1-25, 1933.
Davies, R.: The influence of haemoglobin and ferrous ammonium sulphate on the 
growth of the tubercle bacilli. J .  Path. & Bact. 45:773, 1937.
Dubos, R. J . ,  and Middlebrook, G.: Media for tubercle bacillus. Am. Rev.Tuberc. 
L VI: 334, 1947.
Dunphy, D. L ., and Fousek, M. D.: A simple medium for growth of tubercle 
bacilli. Yale J .  Biol. & Med. 19:1013, 1947.
Evans, B., and Hanks, J . :  Growth of small numbers of acid-fast bacteria in 
blood and serum. Proc. Soc. Exper. Biol. & Med. 40:112, 1939.
Fallin, J .  R., et a l .: Toxic effect of penicillin on the culture of tubercle bacilli. 
Am. J .  Clin. Path. 22:703, 1952.
Frobisher, M., Jr .: Fundamentals of bacteriology. W. B. Saunders Company, 1948.
p. 658. (Petragnani’ s  Medium as modified by Frobisher.)
Gale, D.: The inspissation of egg media for the cultivation of tubercle bacilli. 
Am. Rev. Tuberc. 73:139, 1956.
Herrold, R. D.: Egg yolk agar medium for growth of tubercle bacilli. J .  Infec. 
Dis. 48:236, 1931.
Hirsch, J .  G.: Charcoal media for the cultivation of tubercle bacilli. Am. Rev. 
Tuberc. 70:955, 1954.
Hirsch, J .  G.: Studies on egg yolk growth factors for tubercle bacilli. Am. Rev. 
Tuberc. 70:977, 1954.
Hirsch, J .  G.: The use of charcoal in diluents for tubercle bacilli. Am. Rev. 
Tuberc. 70:989, 1954.
Hirsch, J .  G.: The use of Triton WR 1339 and of malachite green in charcoal 
media for tubercle bacilli. Am. Rev. Tuberc. 71:894, 1955.
Holm, J . ,  and Lester, V.: Diagnostic demonstration of tubercle bacilli. Acta 
tuberc. scandinav. XVI: 2, 1941.
Hudgins, A. K., and Patnode, R. A.: Effect of age of eggs on sensitivity of 
modified Lowenstein medium. Am. J .  Clin. Path. 22:809, 1952.
Kelly, R. G., and Murphy, E. A.: Lowenstein’ s  medium. Am. Rev. Tuberc. 49: 
110, 1944.
Kenny, M.; Johnson, P. M.; and Goldman, M.: A comparative study of three egg 
yolk media in the isolation of M. t u b e r c u l o s i s . Am. Rev. Tuberc. 72:863,1955. 
Kirschner, O.: Die Leistungsfahigkeit der Tiefenkultur des Tuberkelbazillus 
bei Verwendung besonders geeingeter flussiger Nahroboden. Zent. F. Bakt. 
(Abst. 1) 124:403, 1932.
69
Lowe.nstein, E.: Die Methodik der Reinkultur von Tuberkelbazillen aus dem 
Blute. Deutsche med. Wchenschr. LVI:1010, Juni 13, 1930.
Lowenstein, E .: Die Zunchtung der Tuberkelbazillen aus dem Stromenden Blute. 
Zent. f. Bakt. (Abst. 1) 120:127, 1931.
MacNabb, A. L .: Cultural methods of isolation of tubercle bacilli. Am. J .  Pub. 
Health, 26:619, 1936.
McCarter, J .  R., and Kanne, E. M.: Egg mediums for the isolation of all three 
types of tubercle bacilli. J .  Infec. Dis. 71:102, 1942.
Minami, K.: Bactericidal action of oleic acid for tubercle bacilli. I and II. J .  Bact. 
73:338-352, 1957.
Peizer, L ., and Schecter, C.: A new medium for bacteriologic diagnosis of 
tuberculosis. Am. J .  Clin. Path. 20:682, 1950.
Reinisch, E .: Blood medium for routine cultivation of tubercle bacilli. Am. J .  
Clin. Path. 23:929, 1953.
Sasano, K. T ., and Medlar, E. M.: Egg-yolk-potato medium: Its efficacy for demon­
strating small numbers of tubercle bacilli. Am. Rev. Tuberc. 48:297, 1943.
Schwabacher, Herta: A comparison of different media for the growth of the tuber­
cle bacillus. Tubercle 18:199, 1937.
Smith, J .  W.; Humiston, J . ;  Criger, W. P .; and Kirby, W. M.: Evaluation of Dubos’ 
solid medium containing penicillin in isolation of tubercle bacilli. Proc. Soc. 
Exp. Biol. & Med. 70:589, 1949.
Tarshis, M. S., and Frisch, W.: Blood media for the cultivation of M y cob acteriu m  
t u b e r c u l o s i s . Am. J .  Clin. Path. 21:101, 1950.
Tarshis, M. S.; Weed, W. A.; Kinsella, P. C.; Parker, M. V.; and Dunham, W. B .: 
Further experience with a new blood medium for the cultivation of M y co b ac­
terium  t u b e r c u lo s i s .  Am. J .  Pub. Health 45:1157, 1955.
Townsend, S. M.: Elimination of pre-cleaning cage-laid hens’ eggs in preparation 
of egg fluid for tuberculosis bacteriologic media. Am. Rev. Tuberc. 79:677, 
1959.
Wong, S ., and Weinzirl, J . :  An inexpensive synthetic medium for growing M yco­
b ac ter iu m  t u b e r c u lo s i s . Am. Rev. Tuberc. 33:577, 1936.
Woolley, J .  S., and Petrick, F. G.: A potato-egg medium for the isolation of 
tubercle bacilli. Am. Rev. Tuberc. 24:596, 1931.
Yamane, I.: A crystalline substance isolated from egg yolk which promotes 
growth of a minute inoculum of human tubercle bacilli. Nature 179:45-6, 1957.
Zacharias, S. J . :  Isolation of M y co b acteriu m  t u b e r c u lo s is  using blood and plasma 
media. Am. J .  Med. Tech. July-Aug. 1958, pp. 208-210.
A n im a ls
Boden, S. V., and Andersen, M. E.: Diet and experimental tuberculosis in the 
guinea pig. The importance of the source of ascorbic acid. Acta path, et 
microbiol. scandinav. 39:107, 1956.
Calmette, A.: Tubercle bacillus infection and tuberculosis in man and animals. 
Chapters XX-XXIX, Translations by Soper, W. B., and Smith, G. H.: Williams 
and Wilkins Co., Baltimore, 1923.
Eggerth, A. H.; Dresher, E.; and McOsker, V. C.: Infection of chick and duck 
embryos with tubercle bacilli. Am. Rev. Tuberc. 57:632, 1948.
Feldman, W. H., and Magath, T. B.: The reliability of guinea pig inoculation in 
the diagnosis of tuberculosis. Am. Rev. Tuberc. 24:312, 1931.
Feldman, W. H.: A scheme for numerical recording of tuberculous changes in 
experimentally infected guinea pigs. Am. Rev. Tuberc. 48:248, 1943.
Griffith, A. S.: Further experiments on the golden hamster (C r ic e tu s  a u r a tu s )  
with tubercle bacilli and the vole strain of acid-fast bacillus (Wells). J .  Hyg. 
41:260, 1941.
Griffith, A. S.: The relative susceptibility of the field vole to the bovine, human 
and avian types of tubercle bacilli and to the vole strain of acid-fast bacillus 
(Wells, 1937), J .  Hyg. 39:244, 1939.
Hoyt, A., e t  a l .: Sex differences of normal and immunized mice in resistance to 
experimental tuberculosis. Am. Rev. Tuberc. 75:618, 1957.
70
Koras, J .  H., and Lu, G. Y. C.: The diagnosis of tuberculosis by means of the 
hamster. Am. Rev. Tuberc. 17:279, 1928.
Korns, J .  H., and Lu, G. Y. C.: The use of the hamster in the diagnosis of cer­
tain forms of tuberculosis. China M. J .  41:234, 1927.
Lack, C. H.: The pathogenesis of tuberculosis a s  shown in studies of omental 
spreads. Am. Rev. Tuberc. 73:362, 1956.
Lange, B., and Lydtin, K.: Intracutaneous virulence testing in the guinea pig. 
Zent. f. Baku CVIII:22, 1928.
Lester, V.: Saprophytic acid-fast bacilli a s  a source of error in diagnostic work. 
Acta tuberc. scandinav. XIII: 251, 1939.
McNelly, E., and Riddell, W. A.: Use of egg embryos in the culture of M. tu b e r­
c u l o s i s .  Am. J .  Pub. Health 39:1463, 1949.
Moore, M.: The chorioallantoic membrane of chick embryos and its response to 
inoculation with some mycobacteria. Am. J .  Path. 18:827, 1942.
Nugar, J . :  The golden hamster as a test animal for tubercular infection. Nature, 
150:432, 1942.
Patnode, R. A.; Cummings, M.M.; and Spendlove, G. A.: The adaptability of 
mice to the laboratory diagnosis of tuberculosis. J .  Lab. & Clin. Med. 34: 
1081, 1949.
Pierce, C.; Dubos, R.; and Schaeffer: Multiplication and survival of tubercle 
bacilli in the organs of mice. J .  Exper. Med. 97:189, 1953.
Viallier, J . ,  and Lager, S.: Sur le s  caracteres d isinctifs de mycobacterium tuber­
cu losis var. bovis. Comp. Rend. Seances Soc. Biol. 149:118, 1955.
Youmans, G. P ., and Youmans, A. S.: Response of mice to standard infecting 
dose of M y co b acteriu m  t u b e r c u lo s is  var. hominis. Proc. Soc. Exper. Biol. & 
Med. 90:238, 1955.
T h e ra p e u t ic  A g e n ts
Abraham, E. P .: The nature of drugfastness. Tubercle 31:146, 1950.
Albert, A.: Mode of action of isoniazid. Nature 177:525, 1956.
Barclay, W. R., et a l .: Mode of action of isoniazid. Am. Rev. Tuberc. 67:490, 
1953.
Barclay, W. R., and Russe, H.: The in  v itro  action of cycloserine on M. tu b e rc u ­
l o s i s .  Am. Rev. Tuberc. 72:236, 1955.
Barry, V. C. e t  a l . :  Hinconstarch in the treatment of pulmonary tuberculosis. 
Am. Rev. Tuberc. 73:219, 1956.
Barry, V. C., and Edward, D. W.: The metabolic products of hinconstarch. 
Am. Rev. Tuberc. 74:798, 1956.
Brennan, A. J . ,  and Wichelhausen, R. M.: Streptomycin resistant tubercle bacilli. 
Isolation of resistant organisms from pleural fluid prior to institution of 
streptomycin therapy. J.A.M.A. 140:1275, 1949.
Colwell, C. A.; Pitner, G.; and Moravec, M.: The significance of results of 
in  v itro  drug-sensitivity tests with M y co b acteriu m  t u b e r c u lo s i s .  Am. Rev. 
Tuberc. 63:679, 1951.
Committee on Chemotherapy and Antibiotics. The use of PAS in tuberculosis. 
Dis. Chest. 16:904-906, 1949.
Cummings, M. M., e t  a l . :  Effects of cycloserine on M y co b acteriu m  t u b e r c u lo s is  
in v itro . Antibiotics & Chemother. 4:198, 1955.
Delaude, A.; Karlson, A. G.; Carr, D. T .; Feldman, W. H.; and Pfuetze, K. H.: 
Increase in resistance of tubercle bacilli to sodium P-aminosalicylic acid: 
Observations on cultures isolated from patients during chemotherapy. Proc. 
Staff Meetings Mayo Clinic 24:341-346, 1949.
Desbordes, J . ,  and Paraf, M.: A new, entirely synthetic antibiotic which is  active 
against the tubercle bacillus (action of para-amino-salicylic acid in tubercu­
lo sis). L a  Semaine des Hopitaux, 25:296-300, 1949.
Doane, E. A., and Bogen, E.: Streptomycin dependent tubercle bacilli. Am. Rev. 
Tuberc. 64:192, 1951.
Editorial: Rapid appraisal of sensitivity of tubercle bacilli to streptomycin.
Lancet, 1:786-787, May 7, 1949.
71
Epstein, I. G., e t  a l .: The treatment of human pulmonary tuberculosis with cyclo­
serine: progress report. Dis. Chest 29:241, 1956.
Ferebee, S. H., and Palmer, C. E.: Prevention of experimental tuberculosis with 
isoniazid. Am. Rev. Tuberc. 73:1, 1956.
Fisher, M. W.: Sensitivity of tubercle bacilli to streptomycin: An in v itro  study 
of some factors affecting results in various test media. Am. Rev. Tuberc. 
57:58-62, 1948.
Fisher, M. W.: Streptomycin resistant tubercle bacilli: Their development during 
streptomycin therapy of pulmonary tuberculosis. Am. Rev. Tuberc. 57:53-57, 
1948.
Fisher, M. W.: The antagonism of the tuberculostatic action of isoniazid by 
hemin. Am. Rev. Tuberc. 69:469, 19 54.
Grunberg, E., and Blencowe, W.: The influence of pyridoxine on the in v itro  
antituberculous activity of isoniazid. Am. Rev. Tuberc. 71:898, 1955.
Harris, H. W., et a i r .  Comparison of isoniazid concentrations in the blood of 
people of Japanese and European descent. Am. Rev. Tuberc. 78:944, 1958.
Heller, A., e t a ir .  Studies with C l4  labeled para-aminosalicylic acid and isoni­
azid. Am. Rev. Tuberc. 75:71, 1957.
Hines, R. A.: Peripheral neuritis following isoniazid therapy. J.A.M.A. 159: 
1197, 1955.
Hobby, G. L ., and Dougherty, N.: Isolation of a streptomycin resistant organism 
capable of utilizing streptomycin for growth. Proc. Soc. Expef. Biol. & Med. 
69:544-548, 1948.
Hobby, G., e t  a i r .  Late emergence of M. t u b e r c u lo s is  in liquid cultures of pul­
monary lesions resected from humans. Am. Rev. Tuberc. 70:191, 1954.
Howard, W. L .; Maresh, F.; Mueller, E. E .; Yannitellim, S. A.; and Woodruff, C .E .: 
The role of pulmonary cavitation in the development of bacterial resistance 
to streptomycin. Am. Rev. Tuberc. 59:391, 1949.
Karlson, A. G., and Needham, G. M.: Determination of streptomycin sensitivity 
of tubercle bacilli by use of egg-yolk agar medium. Proc. of Staff Meetings of 
Mayo Clinic 23:401, 1948.
Karlson, A. G.; Delaude, A.; Carrl, D. T.; Pfuetze, K. H.; and Feldman, W. H.: 
The occurrence of tubercle bacilli resistant to para-aminosalicylic acid (PAS). 
Dis. Chest 16:667, 1949.
Kendig, I. V., e t a i r .  Psychological side effects induced by cycloserine in the 
treatment of pulmonary tuberculosis. Am. Rev. Tuberc. 73:438, 1956.
Leifheit, H. C., and Smith, E. R. B.: Quantitative estimation of isonicotinic 
acid hydrazide and p-aminosalicylic acid in blood serum. Am. J .  Clin. Path. 
31:142, 1959.
Maher, J .  R.: Mode of action of isoniazid. Am. Rev. Tuberc. 75:517, 1956.
Mitchison, D. A.: A comparison of techniques for measuring the isoniazid resist­
ance of tubercle bacilli. J .  Clin. Path. 6:118, 1953.
Neilands, J .  B.: Metal and hydrogen-ion bonding properties of cycloserine. Arch. 
Biochem. 62:151, 1956.
Poole, N. F ., and Meyer, A. E.: Comparison of new chemical method of determin­
ing isonicotinoyl hydrazide in serum with microbiological assay . Proc. Soc. 
Exper. Biol. & Med. 98:375, 1958.
R eiss, J . ,  and Townsend, S. M.: The rising incidence of isoniazid-resistance: 
its  clinical significance. Dis. Chest 32:274, 1957.
Tucker, W. B.: An account of the cooperative investigation of the Veterans Ad­
ministration, Army and Navy. Three papers. I. Am. Rev. Tuberc. 72:718, 1955. 
II. Am. Rev. Tuberc. 72:733, 1955. III. ib id .  72:756, 1955.
U. S. Public Health Service Tuberculosis Prophylaxis Trial: Prophylactic effects 
of isoniazid on primary tuberculosis in children. Am. Rev. Tuberc. 76:942, 
1957.
Weiss, P. J . :  A new colormetric test for the estimation of dihydrostreptomycin. 
Antibiotic & Chemother. 6:653, 1956.
Weiss, W., e t  a i r .  Impact of isoniazid on tuberculous meningitis. J.A.M.A. 
164:947, 1957.
72
Williston, E. H., and Youmans, G. P .: Streptomycin resistant strains of tubercle 
bacilli: Production of streptomycin resistance in v itr o . Am. Rev. Tuberc. 
55:536-539, 1947.
Williston, E. H., and Youmans, G. P .: Factors affecting the sensitivity in v itro  
of tubercle bacilli to streptomycin. Am. Rev. Tuberc. 59:336, 1949.
Yegian, D., e t a l . :  Para-aminosalicylic acid in the sputum. II. Elimination of 
its effect on culture for tubercle bacilli. Am. Rev. Tuberc. 71:860, 1955.
Youmans, G. P .; Williston, E. H.; and Osborne, R. R.: Occurrence of strepto­
mycin resistant tubercle bacilli in mice treated with streptomycin. Proc. Soc. 
Exper. Biol. & Med. 70:36-37, 1949.
V iru le n ce  an d  V ar ia tio n
Beaver, P. W., and Bayne-Jones, S.: Mycobacterium Ryan strain, isolated from 
pleural exudate. J .  Infect. Dis. 49:399, 1931.
Bloch, H., and Noll, H.: Studies on the virulence of tubercle bacilli. The effect 
of cord factor on murine tuberculosis. Brit. J .  Exper. Path. 36:8, 1955.
Branch, A. S.: Study of acid-fast organisms other than mammalian tubercle ba­
cilli isolated from disease in man; occurrence of avian tubercle bacillus in­
fection of man and diagnosis of avirulent avian tubercle bacilli. Tubercle 
14:337, 1933.
Buhler, V. B., and Poliak, A.: Human infection with atypical acid-fast organisms. 
Am. J .  Clin. Path. 23:363, 1953.
Hauduroy, P .: L a  virulence des Mycobacteries. Rev. immunol. 18:62, 1954.
Karlson, A. G., and Ikemi, Y.: Comparison of the virulence for mice and guinea 
pigs of an isoniazid-sensitive tubercle bacillus and its isoniazid-resistant 
variant. Proc. Staff Meetings Mayo Clinic 29:119, 1954.
Middlebrook, G., and Cohn, M. L .: Some observations on the pathogenicity of 
isoniazid-resistant variants of tubercle bacilli. Science 118:297, 1953.
Morse, W. C.; Weiser, 0 . L ; Kuhns, D. M.; Fusillo, M.: Study of the virulence 
of isoniazid-resistant tubercle bacilli in guinea pigs and mice. Am. Rev. 
Tuberc. 69:464, 1954.
Norden, A., and Linell, F .: A new type of pathogenic mycobacterium. Nature 
168:826, 1951.
Pinner, M.: Atypical acid-fast microorganisms; chromogenic acid-fast bacilli 
from human beings. Am. Rev. Tuberc. 32:424, 1935.
Raffel, S.: Pathogenicity of the tubercle bacillus. Proc. Soc. Exper. Biol. & 
Med. 64:507, 1947.
Smithbum, K. C.: Virulence of tubercle bacilli. Its variations attendent on animal 
p assage . Am. Rev. Tuberc. 39:116, 1939.
Tarshis, M. S., and Frisch, A. W.: Chromogenic acid-fast bacilli from human 
sources. Am. Rev. Tuberc. 65:278, 1952.
Yegian, D., and Budd, .V.: Certain non-pathogenic mycobacteria a s  a source of 
error in diagnosis of drug-susceptibility tests. Am. Rev. Tuberc. 68:557,1953.
B . C . G .
American Trudeau Society: A. T. S. States policy on B. C. G. Bull. N. T. A. 
March 1948.
Aronson, J . ,  and Palmer, C. E .: Experience with B. C. G. in the control of 
tuberculosis among North American Indians. Pub. Health Rep. 61:802, 1946.
Birkhaug, K.: A detachable spring actuated multiple puncture apparatus for 
B. C. G. vaccination.. Am. J .  Clin. Path. 19:492, 1949.
Birkhaug, K .: B. C. G. and the newer epidemiology of tuberculosis. Bull. N. J .  
Acad. Med. 24:411, 1948.
Boquet, A.: The pathogenic properties of B. C. G. Am. Rev. Tuberc. 24:764,1931.
Calwell, H. G.: Fatal case of tuberculosis produced by B. C. G. Am. Rev. 
Tuberc. 73:301, 1956.
Coello, G.: B. C. G. vaccination (a review). Indian J .  of Med. Sci. 2:755, 1948.
73
Cohn, M. L .; Davis, C. L .; and Middlebrook, G.: Airborne immunization against 
tuberculosis. Science, 128:1282, 1958.
Dahlstrom, G.: The future of BCG vaccination. Acta tuberc. scandinav. 32: 
250, 1956.
Dubos, R. J . ,  e t a l . :  Differential characteristics in  v itro  and in v iv o  of several 
substrains of B. C. G. IV. Immunizing effectiveness. Am. Rev. Tuberc. 74: 
699, 1956.
Dubos, R. J . ,  e t a l :  Report of ad  h oc  advisory committee on BCG to the Surgeon 
General of the United States Public Health Service. Am. Rev. Tuberc. 76: 
726, 1957.
Editorial: BCG vaccination against tuberculosis. J.A.M.A. June 1957.
Federal Security Agency: Selected references to articles on BCG. F. S. A. Bulletin.
Flakmer, S., e t a l . :  Fatal tuberculosis from BCG vaccination. Acta Pediat. 44: 
219, 1955.
Hollstromm E., and Hard, S.: A fatality from BCG vaccination. Acta dermat. 
venereol. 33:159, 1953.
Hyge, T . V.: The efficacy of BCG vaccination. Acta tuberc. scandinav. 32:
(89), 1956
Levine, M. I.: An evaluation of the use of BCG in the prevention of tuberculosis 
in infants and children. Am. J .  Pub. Health 37:1089, 1947.
Medical Advisory Committee of Research Foundation: Why have we not accepted 
BCG vaccination? J .  A. M. A. 164:951, 1957.
Meyer, J . :  A fatal case of tuberculosis produced by BCG. Am. Rev. Tuberc. 
70: 402, 1954.
Rosenthal, S. R.: The preservation of BCG by freeze-drying. Acta tuberc. 
scandinav. 26:106, 1952.
I b id .:  Standardization and efficacy of BCG vaccination aginst tuberculosis.
Twenty year study: a critical evaluation. J.A.M.A. 157:801, 1955.
Tuberculosis Program, Public Health Service, U.S.A.: Experimental studies of 
vaccination, allergy, and immunity in tuberculosis. Papers I—III, Bull. World 
Health Org. 12:13-62, 1955; Papers IV-VI, Am. J .  Hyg. 62:168-199, 1955.
U. S. Public Health Service, Tuberculosis Control Division: Story of B. C. G. 
Int. Med. Digest, May 1948.
Wallgren, A. J . :  BCG: Past, present, and future. Am. Rev. Tuberc. 76:715, 1957.
T u b e rcu lin  T e s t
Chesrow, E. J . ,  et a l . :  Tuberculin testing of the aged. Dis. Chest. 32:2, 1957.
Choremis, C., et a l . :  Effects of isoniazid on allergy. Am. Rev. Tuberc. Supple­
ment, August 1956, 197-208.
Corper, H. J . ,  and Clark, C.: Autolytic tuberculin. Am. Rev. Tuberc. 54:401,1946.
Holm, J . ,  and Lind, P .: Standardization of tuberculin. Pub. Health Rep. 62: 
188, 1947.
Jensen, ft. A., and Lind, P .: Specificity of purified tuberculins. Acta tuberc. 
scandinav. 17:37, 1943.
Low, E .: Mantoux and Heaf multiple puncture tuberculin tests: comparison in 
BCG vaccinated and unvaccinated subjects. Tubercle 37:102, 1956.
Palitz, L . S ., and Aronsohn, M. H.: Tuberculin sensitivity in the aged. Am. Rev. 
Tuberc. 75:461, 1957.
Pepys, J . :  The relationship of nonspecific and specific factors in the tuberculin 
reaction. Am. Rev. Tuberc. 71:49, 1955.
Raffel, S.: The relationship of acquired resistance, allergy, antibodies, and 
tissue reactivities to components of the tubercle bacillus. Am. Rev. Tuberc. 
54:564, 1946.
Raffel, S.: Chemical factors involved in the induction of infectious allergy. 
Experientia 6:410, 1950.
Schwartz, S., e t a l . . :  A tuberculin survey in a metropolitan district and its re­
lation to morbidity and mortality. Dis. Chest 28:21, 1955.
Seibert, F . B., and Dufour, E .: A study of certain problems in the use of standard 
tuberculin fractionation of P.P.D . Am. Rev. Tuberc. 58:36 3, 1948.
Seideman, R. M.: A comparative study of O.T. and P.P.D . Am. J .  Hyg. 30:1,1939.
Woodruff, C. E .: Quantitative tuberculin test. Am. Rev. Tuberc. 55:488, 1947.
74
Advances in carbohydrate chemistry: Vol. 3 edited by Pigman, W. W. and Wofom, 
M. L . f New York, Academic P ress, Inc., 1946.
Anderson, R. J . :  The chemistry of the lipids of tubercle bacilli. Harvey Lectures 
35:271, 1940.
Anderson, R. J . :  The chemistry of the lipids of the tubercle bacillus. Yale J .  
Biol. & Med. 15:311, 1943.
Anderson, R. J.: Introduction to bacteriological chemistry. Baltimore, Williams 
and Wilkins, 1946.
Asselineau, J . :  L ipids du bacille tuberculeux. Prog. Explor. Tuberc. 5:1, .New 
York, S. Karger, Bale, 1952.
Asselineau, J . ,  and Lederer, E .: Sur la  constitution du “ cord factor”  isole' d’une 
souche humaine de bacille tuberculeux. Biochim. et biophys. acta 17:161, 1955,
Bloch, H., e t a l . : A toxic lipid component of the tubercle bacillus (“ Cord Factor” ) . 
I. Isolation from petroleum ether extracts of young bacterial cultures. Am. Rev. 
Tuberc. 67:629, 1953; Noll, H., and Bloch, H.: Ib id ,  II. Occurrence in chloro­
form extracts of young and older bacterial cultures. Am. Rev. Tuberc. 67: 
828, 1953. Asselineau, J . ,  e t a l . :  Ib id ,  III. Occurrence and distribution in 
various bacterial extracts. Am. Rev. Tuberc. 67:853, 1953.
Bloch, H., et a l . :  Constituents of a “ toxic-lipid”  obtained from M y co b acteriu m  
tuberculosis. Biochim. e t biophys. acta 23:312, 1957.
Foldes, J . :  The nature of specific polysaccharides of tubercle bacilli. Acta 
mycol. Acad, Scient. Hung. 2:297-313, 1955.
Ginsberg, B., e t a l . :  Amino acid composition of Mycobacteria. Arch. Biochem. 
60:164, 1956.
Goldman, D. S.: Enzyme systems in the mycobacteria. I. The isocitric dehydro­
genase. J .  Bact. 71:732, 1956.
I b id . :  II. The malic dehydrogenase. J .  Bact. 72:401, 1956.
I b id . :  III. The condensing enzyme. J .  Bact. 73:602, 1957.
Malek, I., and Sterzl, J . :  L e s  substances nucleaires du bacille tuberculeux. 
Comptes Rendes des Seances de la Societe de Biolgie 142:1053, 1948.
Menzel, A. E. 0 . ,  and Heidelberger, M.: Protein fractions of the human strain, 
H-37, of tubercle bacillus. J .  Biol. Chem. 124:89, 1938.
Noll, H., and Bloch, H.: Studies on the chemistry of the cord factor of M yco­
b ac te r iu m  tuberculosis. J .  Biol. Chem. 214:251, 1955.
Noll, H., e t a l . :  The chemical structure of the cord factor of M ycobacteriu m  
t u b e r c u lo s i s .  Biochim. et biophys. acta 20:299, 1956.
Seibert, F .: The chemical composition of the active principle of tuberculin and 
the isolation in crystalline form and identification of the active principle of 
tuberculin. Am. Rev. Tuberc. 17:402, 1928.
Seibert, F .: A history of the development of P.P.D . Am. Rev. Tuberc. 44:1,1941.
Seibert, F .: The chemistry of tuberculin. Chem. Rev. 34:107, 1944.
Seibert, F . B.: Constituents of mycobacteria. Ann. Rev. Microbiol. 4:35, 1950.
Seibert, F. B., et a l . :  Isolation, identification and classification  of protei. s  ol 
tuberculin and the tubercle bacillus. Am. Rev. Tuberc. 71:704, 1955.
Stacey, M., e t a l . :  Polysaccharide complexes isolated from M. t u b e r c u lo s is  
(human strain). Biochim. et biophys. acta 7:146, 1951.
Steenken, W.: The isolation of purified protein derivatives and carbohydrates 
from tuberculins and their biological properties. J .  Biol. Chem. 141:91,1941.
H e m a to lo g y
Allgower, M., and Bloch, H.: The effect of tubercle bacilli on the migration of 
phacytes in v itro . Am. Rev. Tuberc. 59:562, 1949.
Bloch, H.: The relationship between phagocytic ce lls  and human tubercle bacilli. 
(Good references) Am. Rev. Tuberc. 58:662, 1948.
Brocard, H.; Grivaux, M.; and B asset, G.: Haemotological tests of progress 
during the treatment of certain forms of pulmonary tuberculosis with strep- 
mycin. P aris Med. 39:118, 1949.
Favour, C.; Fremont-Smith, P.; and Miller, J .  M.: Factors affecting in  v itro  
cytolysis of W.B.C. by tuberculin. Am. Rev. Tuberc. 60:212, 1949.
Biochemistry
75
Gilliland, 1. C., e t  a l . :  Serum proteins in pulmonary tuberculosis. Brit. M. J . 
p. 1460, 1956.
Heilman, D. H.; Feldman, W. H.; and Mann, F .: Specific cytotoxic action of 
tuberculin. Am. Rev. Tuberc. 52:1945.
Hotopp, M., and Kahn, M. C.: The fate of phagocytized acid-fast bacteria as 
determined by the single cell method. J .  Infect. Dis. 58:324, 1936.
Sabin, F. R., e t a l . :  Studies on tuberculosis. J .  Exper. Med. 52:1-151, 1930 
(Supp. No. 3).
S e ro lo g y
Caulfeild, A. H. W.: The tuberculo-complement fixation and inhibition test. Am. 
Rev. Tuberc. 11:509, 1925.
Dozier, S. M., e t  a l . :  Demonstration of circulating antibodies to M. t u b e r c u lo s is  
in humans. I. Am. Rev. Tuberc. 75:949, 1957. II. Fusillo, et a l . ,  Am. Rev. 
Tuberc. 75:954, 1957.
Freund, G., and Walter, A.: Saprophytic acid-fast bacilli and paraffin oil as 
adjuvants in immunization. Proc. Soc. Biol. & Med. 56:47, 1944.
Gerstl, B., e t  a l . :  Detection of apparently absent circulating antibodies in 
tuberculous sera. Am. Rev. Tuberc. 72:345, 1955.
Heidelberger, M.: Chemical aspects of the precipitin and agglutination reaction. 
Chem. Rev. 24:323, 1939.
Labzoffsky, N. A.: Experiences with a new antigen for a complement fixation 
test in tuberculosis. Canad. J .  Microbiol. 1:794, 1955.
Labzoffsky, N. A., e t  a l . :  Complement fixing antibodies in tuberculous guinea 
pigs. Canad. J .  Microbiol. 2:461, 1956.
Lagercrantz, R.: Immunological studies of mycobacteria, (two papers) Acta path, 
et microbiol. scandinav. 38:416-432, 1956.
Lewis, P. A.: The complement fixation reaction as applied to tuberculosis. 
Am. Rev. Tuberc. 3:129, 1919-20.
Middlebrook, G., and Dubos, R.: Specific serum agglutination of erythrocytes 
sensitized with extracts of tubercle bacilli. J .  Exper. Med. 88:521, 1948.
Parlett, R. C., e t  a l . :  The detection of antibodies in the serum of tuberculous 
patients by an agar double-diffusion precipitation technique. Am. Rev. 
Tuberc. 77:462, 1958.
Rheins, M., e t  a l . :  Serologic investigations of mycobacterial antigens. (Five 
papers) I. Am. Rev. Tuberc. 73:563, 1956. II. Ib id ,  73:571, 1956. III. Ib id , 74: 
756, 1956. IV, Ib id , 74:764, 1956. V. Ib id , 75:958, 1957.
Rheins, M., e t  a l . :  Tuberculous antibodies demonstrated by agar diffusion.
I. Specificity and incidence of agar-diffusion antibodies in rabbit sera. Am. 
Rev. Tuberc. 74:229, 1956; Burrell, R. G., e t a l .  Ib id  II. Further characteri­
zation of these antibodies and their distribution in human tuberculous sera. 
Am. Rev. Tuberc. 74:239, 1956.
Sasana, K. T .: Further studies on the complement fixation test for tuberculosis. 
Am. Rev. Tuberc. 9:136, 1924.
Seibert, F. B., e t  a l . :  The significance of antibodies to tuberculoprotein and 
polysaccharide in resistance to tuberculosis. Am. Rev. Tuberc. 73:547, 1956.
C lin ic a l  L a b o r a to ry  T e s t s
Gleich, M.: Levison test. Am. J .  Dis. Child. XLIII:1077, 1932.
Levya, J .  F .: Biochemical studies on tuberculosis. VI. The diagnostic signi­
ficance of the nucleic acid test in tuberculosis. J .  Phil. Med. Assn. 25:75-81, 
1949.
Mendel, L .: Daranyi reaction. Jahrb. Kinderheilk. CVI:15, 1924.
Seibert, F. B.; Pfaff, M. L .; and Seibert, M. V.: A serum polysaccharide in tuber­
cu losis and carcinoma. Arch. Biochem. 18:279, 1948.
Seibert, F. B .; Seibert, M. V.; Atno, J . ;  and Campbell, H. W.: Variations in pro­
tein and polysaccharide content of sera in the chronic d iseases tuberculosis, 
sarcoidosis and carcinoma. J .  Clin. Invest. 26:90, 1947.
76
Tanner, F. H., and Tolman, P. J . :  The Weltman serum coagulation test. Am. J .  
Clin. Path. 11:528, 1941.
Wuhrmann, F. H., and Wunderly, C. H.: The cadmium reaction. J .  Lab. & Clin. 
Med. 34:1162, 1942.
D is in fe c t a n t s
Frobisher, M., Jr., and Sommermeyer, L : A study of the effect of alcohols on 
tubercle bacilli and other bacteria in sputum. Am. Rev. Tuberc. 68:419, 1953.
Frobisher, M. Jr ., e t a l .: Studies on disinfection of clinical thermometers. I. Oral 
thermometers. App. Microb., 1:187, 1953.
Green, L .: The effect of triethyleneglycol upon M y c o b a c te r ia . Tuberkulosearzt 
6:177, 1952.
Hirsch, J .  G.: The resistance of tubercle bacilli to the bactericidal action of 
benzalkonium chloride (Zephiran). Am. Rev. Tuberc. 70:312, 1954.
Lawrence, C. A., and Grover, A. A.: Hospital sterilizing solutions. Bull. Am. 
Soc. Hosp. Pharm. 8:224, 1951.
Ritter, H. W.: The germicidal effect of a quaternary ammonium compound (cetyl- 
pyridinium chloride) on M y co b acteriu m  t u b e r c u lo s i s .  App. Microb. 4:114,1956.
Smith, C. R.: Alcohol a s  a disinfectant against the tubercle bacillus. Pub. Health 
Rep. 62:1285, 1947.
Smith, C. R.: The bactericidal effect of surface active agents on tubercle 
bacilli. Pub. Health Rep. 65:1588, 1950.
Wolinsky, E ., e t  a l . :  Tuberculocidal activity of clorpactin, a new chlorine 
compound. Antibiot. Med. 1:382, 1955.
S p e c ia l  T e ch n iq u e  s
Cooke, G. M., et a l . :  Staining of bacterial colonies on the millipore filter to 
improve contrast. Stain Tech. 32:63, 1957.
Coster, J .  F ., and Manten, A.: A simple technique for the differentiation of 
tubercle bacilli and saprophytic mycobacteria. Am. Rev. Tuberc. 74:958, 1956.
Crowle, A. J . :  Lung density as a measure of tuberculous involvement in mice. 
Am. Rev. Tuberc. 77:681, 1958.
Dubos, R. J . ,  and Middlebrook, G.: Cytochemical reaction of virulent tubercle 
bacilli. Am. Rev. Tuberc. 58:698, 1948.
Fenner, F .: The enumeration of viable tubercle bacilli by surface plate counts. 
Am. Rev. Tuberc. 64:353, 1951.
Froman, S., e t a l . :  Bacteriophage active against virulent M y co b acteriu m  tu b e r­
c u l o s i s .  I. Isolation and activity. Am. J .  Pub. Health 44:1326, 1954.
Froman, S., et a l . :  Bacteriophage susceptibility and cultural characteristics of 
BCG and other tubercle bacilli. Dis. Chest 28:377, 1955.
Goldman, E. C., and Goldman, 0. S.: Cording and neutral red reaction of two 
avirulent strains of mycobacterium. Am. Rev. Tuberc. 73:674, 1956.
Haley, L . D., and Arch, R.: Use of millipore membrane filter in the diagnostic 
tuberculosis laboratory. Am. J .  Clin. Path 27:117, 1957.
Hauduroy, P ., and Pastemak-Gallia, Y.: Sur une re'action cytochemique en rap­
port avec la  virulence des mycobacte'ries. Ann. Inst. Pasteur 77:91, 1949.
Jones, W. D., Jr .: Simple method for maintaining stock cultures of mycobacterium 
species. Am. J .  Clin. Path. 27:363, 1957.
Koch-Weser, D., and Ebert, R. H.: Tetrazolium reduction by tubercle bacilli. 
J .  Lab. Clin. Med. 46:608, 1955.
Konno, K.: New chemical method to differentiate human-type tubercle bacilli 
from other mycobacteria. Science 124:98 5, 1956.
Krasnow, I., e t  a l . :  A microcolonial test for the recognition of virulent myco­
bacteria. Am. Rev. Tuberc. 71:361, 1955.
Lack, C. H.: The pathogenesis of tuberculosis a s  shown in studies of omental 
spreads. Am. Rev. Tuberc. 73:362, 1956.
Melvin, 1. G., and Vandiviere, H. Mac.: The titration of cord formation a s  re­
lated to virulence of mycobacteria. Am. Rev. Tuberc. 78:83, 1958.
77
Middlebrook, G.; Dubos, R. J . ;  and Pierce, C. H.: Virulence and morphological 
characteristics of mammalian tubercle bacilli. J .  Exper. Med. 86:175, 1947.
Morse, W. C.; Dail, M. C.; and Olitzky, I.: A study of the neutral red reaction 
for determining the virulence of mycobacteria. Am. J .  Pub. Health 43:36, 1953.
Parlett, R., and Youmans, G. P .: Antigenic relationships between mycobacteria 
as determined by agar diffusion precipitin techniques. Am. Rev. Tuberc. 73: 
673, 1956.
I b id .:  Antigenic relationships between ninety-eight strains of mycobacteria
using gel-diffusion precipitation techniques. Am. Rev. Tuberc. 77:450, 1958.
Runyon, E. H., e t a l Distinguishing mycobacteria by the niacin test. Am. Rev. 
Tuberc. 79:663, 1959.
Schweiger, 0 . ,  e t a l . :  Studies on the catalase enzyme of mycobacteria. I. Corre­
lation between catalase activity and virulence of mycobacteria under certain 
experimental conditions. Am. Rev. Tuberc. 77:146, 1958.
Viallier, J . ;  Kalb, J .  C.; and Tiguad, J . :  Sur la coloration par le rouge neutre du 
bacille tuberculeux. Compt. Rend. Soc. de Biol. 144:1513, 1950.
Will, D. W., e t  a l . :  Cultural characteristics and drug and bacteriophage resistance 
of avian tubercle bacilli. Am. Rev. Tuberc. 76:435, 1957.
Wilson, F. J . ,  e t  a l . :  Use of oxidation-reduction dyes in the determination of 
virulence of mycobacteria in v itro . Am. Rev. Tuberc. 65:187, 1952.
Wrinkle, C. K., and Patnode, R. A.: A test tube modification of the oxidation- 
reduction dye test for the determination of virulence of mycobacteria in v itro .  
Am. Rev. Tuberc. 66:99, 1952.
A ty p ic a l  A c id -F a s t  B a c i l l i
Buhler, V. B., and Poliak, A.: Human infection with atypical acid-fast organ­
ism s. Am. J .  Clin. Path. 23:363, 1953.
Crow, H. E., e t a l . :  A limited clinical, pathologic, and epidemiologic study of 
patients with pulmonary lesions associated  with atypical acid-fast bacilli 
in the sputum. Am. Rev. Tuberc. 75:199, 1957.
Gastambide-Odier, M. M., e t  a l . :  Comparison of the native lipids of atypical acid- 
fast bacilli with the lipids of known mycobacterial types. Am. Rev. Tuberc. 
75:843, 1957.
Gastambide-Odier, M. M., and Smith, D. W.: A rapid means of differentiating 
atypical acid-fast bacilli and avian tubercle bacilli from other mycobacteria. 
Am. Rev. Tuberc. 77:662, 1958.
Gordon, R. E., and Smith, M. M.: Rapidly growing, acid-fast bacteria. II. Species’ 
description of M y co b acteriu m  fortu itum  Cruz. J .  Bact. 69:502, 1955.
Huppert, M., e t  a l . :  Characterization of atypical mycobacteria and of Nocardia 
species isolated from clinical specimens. II. Procedure for differentiating 
between acid-fast mircoorganisms. Am. Rev. Tuberc. 76:468, 1957.
Keltz, H., e t a l . :  A characterization of atypical acid-fast bacilli obtained from* 
patients with pulmonary tuberculosis. Dis. Chest 34:368, 1958.
Koch, M. L ., e t  a l . :  The selective activity of fluid thioglycollate medium for 
group differentiation of atypical chromogenic mycobacteria, M y co b acteriu m  
t u b e r c u lo s i s ,  and saprophytic mycobacteria. Am. Rev. Tuberc. 77:356, 1958.
Konno, K., e t  a l . :  Differentiation of human tubercle bacilli from atypical acid- 
fast bacilli. I. and II. Am. Rev. Tuberc. 77:669, 1958.
Kushner, D. S., e t a l . :  Atypical acid-fast bacilli. II. M y co b acteriu m  fo rtu itu m : 
Bacteriologic characteristics and pathogenicity for laboratory animals. 
Am. Rev. Tuberc. 76:108, 1957.
McMillen, S., and Kushner, D. S.: Atypical acid-fast bacilli. I. A cultural scheme 
for rapid identification. Am. Rev. Tuberc. 76:103, 1957.
Poliak, A., and Buhler, V. B.: The cultural characteristics and animal patho­
genicity of an atypical acid-fast organism which cau ses human d isease. 
Am. Rev. Tuberc. 71:74, 1955.
Runyon, E. H.: Anonymous mycobacteria in pulmonary d isease. Med. Clinics 
N. America 43:273, 1959.
78
Tarshis, M. S.: Preliminary observations on the development of atypical (chro- 
mogenic) variants of the H37Rv strain of M. t u b e r c u lo s is  under the influence 
of streptomycin and isoniazidin  v itro . Am. Rev. Tuberc. 78:921, 1958.
Timpe, A., and Runyon, E. H.: The relationship of “ atypical”  acid-fast bac­
teria to human d isease. J .  Lab. Clin. Med. 44:202, 1954.
Wayne, L . G., e t  a l Characterization of atypical mycobacteria and of Nocardia 
species isolated from clinical specimens. Am. Rev. Tuberc. 76:451, 1957.
Wayne, L . G.: Quantitative aspects of neutral red reactions of typical and atypical 
mycobacteria. Am. Rev. Tuberc. 79:526, 1959.
Wolinsky, E., e t a l . :  Atypical chromogenic mycobacteria associated with pul­
monary d isease . Am. Rev. Tuberc. 75:180, 1957.
Wolinsky, E., e t  a l . :  Drug susceptibilities of 20 “ atypical”  as compared with 
19 selected strains of mycobacteria. Am. Rev. Tuberc. 76:497, 1957.
Wood, L . E., e t a l . :  Human infections with the “ yellow”  acid-fast bacillus. Am. 
Rev. Tuberc. 73:917, 1956.
79
*  U .S . G O V E R N M E N T  P R IN T IN G  O F E IC E  : I9 6 0  0  —  5 5 2 3 2 6
.
